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Abstract 
In the olfactory epithelium (OE) the detection of volatile compounds (odors) is 
accomplished by a large family of olfactory receptors (ORs), located on the surface of 
the cilia of olfactory sensory neurons (OSNs). These represent the major sensory 
component of the OE and reside in the nasal cavity. The extraordinary chemical 
diversity of olfactory ligands is matched in the mouse genome by a collection of more 
than 1200 mouse and 350 human active OR genes encoding for G-protein-coupled 
receptors (GPCRs).  
Each mature OSN in the OE is thought to express only one allele of a single OR gene 
(monoallelic and monogenic expression). A given OR gene is expressed in a mosaic or 
punctate pattern of OSNs within a characteristic zone of the OE.  
The transcriptional mechanisms that underlie this extraordinarily tight regulation of 
gene expression remain unclear.  
I hypothesize that OR expression choice can be influenced by somatic LINE-1-
associated genomic variations. Indeed, it is now well established that active LINE-1s 
can create genomic rearrangements at insertional and post-insertional stages. Besides 
promoting genome plasticity and diversification during evolution, somatic variations 
can contribute to gene expression regulation for those genes that are characterized by a 
stochastic and monoallelic expression.  
Under this hypothesis, I expect the genomic sequence around the expressed ORs to 
be different with respect to that around the same ORs in non-expressing cells, for the 
presence of variations able to activate chromatin and promote ORs transcription.  
I first showed high LINE-1 expression and retrotransposition in OE. Then I 
investigated the presence and involvement of LINE-1-associated variations with OR 
expression, comparing the genomic sequence around an active and an inactive OR 
locus.  
In particular, I analyzed a genomic region of 50 kb around the Olfr2 TSS taking 
advantage of a GFP knock-in mouse. In these mice, the OSNs naturally expressing 
Olfr2 co-express also GFP. Targeted sequencing of Olfr2 locus revealed hundreds of 
heterozygous structural variants (insertions, deletions, inversions and duplications) in 
the vicinity of the locus. Deletions were the most abundant variation category. 
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By end point PCR I validated six LINE-1 associated deletions potentially involved in 
Olfr2 expression. Nevertheless, functional validation experiments in vivo will be 
performed to prove their effective role in Olfr2 choice.  
Looking at the putative mechanisms supporting the deletions, I started investigating a 
possible involvement of DSBs. With this aim, I performed a chromatin 
immunoprecipitation and sequencing (ChIP-Seq) analysis for endogenous -H2AX (an 
early response marker for DNA-DSBs) in mouse OE and liver. I performed a general 
characterization of endogenous -H2AX in normal tissues. In both tissues analyzed, -
H2AX signal was not randomly distributed in the genome but preferentially localized 
within transcribed and regulatory regions. 
Overall, -H2AX peaks were depleted in the OR clusters. Interestingly, an exception 
was given by a peak located within the Olfr2 locus, in close proximity to two validated 
deleted regions.
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Abbreviations 
 
CDS Coding Sequence 
Cer Cerebellum 
ChIP-Seq Chromatin ImmunoPrecipitation sequencing 
CNV Copy Number Variation 
DRS Direct Repeat Site 
DSB Double Strand Break 
EN Endonuclease 
GBC Global Basal cell 
gDNA Genomic DNA 
GFP Green fluorescent protein 
H2AX Phosphorylated-H2AX 
GPCR G-protein coupled receptor 
HBC Horizontal Basal cell 
H Hippocampus 
HR Homologous recombination 
IHC Immunohistochemestry 
IP Immunoprecipitation 
IR Inverted repeat 
IRES Internal-ribosomal entry site 
ITR Inverted terminal repeat 
K Kidney 
L Liver 
LCM Laser capture microdissector 
LCR Locus control region 
LINE-1 Long interspersed nuclear element-1 
LSD1 Lysin demethylase 1 
LTR Long terminal repeat 
MDA Multiple Displacement Amplification 
NAHR Non-Allelic Homologous Recombination 
NanoCAGE Cap analysis of gene expression 
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NHEJ Non-homologous end joining 
NPC Neural precursor cell 
O/N Over night 
OB Olfactory bulb 
OE Olfactory epithelium 
Olfr2 Olfactory receptor 2 
OR Olfactory Receptor 
ORF Open Reading Frame 
OSN Olfactory Sensory Neuron 
pA Poly-A tail 
PB Pac Bio 
PCR Polymerase chain reaction 
Poll II RNA Polymerase II 
RNP Ribonucleoprotein 
RT Retrotranscriptase 
RT Room Temperature 
RT-qPCR Real Time quantitative PCR 
SC Supporting Cell 
SINE Short interspersed nuclear element 
SSA Single strand annealing 
SV Structural variation 
TE Transposable element 
Topo II Topoisomarase II 
TPRT Target primed reverse transcription 
TSD Target site duplication 
TSS Transcription start site 
ub-H2AX Ubiquitinatinated-H2AX 
UPR Unfolded protein response 
UTR Untranslated region 
VNO Vomeronasal organ 
VR Vomeronasal receptor 
WB Western blot 
WGA Whole genome amplification 
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1 Introduction 
Here I present the main biological concepts at the basis of this work.  
In the first section I give a general overview of the mouse olfactory system, focusing 
on the problem of OR transcriptional regulation in mouse OE.  
In the second section I describe the general features of transposable elements with 
particular attention to the effects of LINE-1 retrotransposition on the genome stability. 
In the third section I describe how transposable elements can modulate gene 
expression. 
Finally, in the fourth section I introduce the relationship between transposable 
elements and DNA-double strand breaks repair systems. 
1.1 The olfactory system 
One of the most fascinating questions in neurobiology is how myriads of external 
stimuli can be rapidly perceived, processed by the brain and finally drive mammalian 
behavior. The detection of an external stimulus is accomplished by different sensory 
systems, among which the one responsible for the sense of smell is still functionally 
poorly characterized. In this work we focused our investigation on the olfactory system 
of mice, since they are a well-characterized and representative experimental model to 
study molecular mechanisms involved in mammalian olfaction. 
Even though olfaction in mice has a principal role, the belief that olfaction is a 
secondary sense in human, compared to other species that rely on smell to detect food, 
predators and mates, is overly simplistic. Emerging evidence, like the discovery that 
hundreds of thousands of distinct odors can be discriminated by human nose and the 
discovery of the early impairment of olfaction in many neurodegenerative diseases 
(Barresi et al. 2012), highlighted the importance of studying this chemosensory system 
even in humans. 
During the last thirty years the development of new technologies allowed to start 
answering some fundamental questions about olfaction, from the molecular identity of 
ORs to the interpretation of how olfactory information is coded in the brain (Nagai, 
Armelin-Correa, and Malnic 2016). While these discoveries represent a solid starting 
point, there are still open questions about olfaction. One of these regards the molecular 
mechanisms underlying OR expression. 
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1.1.1 Mouse Olfactory Epithelium (OE) 
In mouse, the olfactory system consists of two main organs: the main OE and the 
olfactory bulb (OB). Olfactory perception begins when odorous ligands activate ORs 
expressed in olfactory sensory neurons (OSNs) of the OE. The OE is located in the 
posterior upper part of the nasal cavity where it is arranged over multiple cartilaginous 
structures called turbinates (Figure 1.1). It is composed by at least four different cell 
populations and each of these cell types occupies a specific position in the 
neuroepithelium (Figure 1.2).  
 
 
Figure 1.1. Mouse olfactory system. Sagittal cross section through the nasal region of the head: main 
olfactory epithelium (OE) and main olfactory bulb (OB) are shown in green, and the two layers of the 
vomeronasal organ (VNO) and corresponding connection regions in the accessory olfactory bulb (AOB) 
are shown in yellow and red (Brennan and Zufall 2006) 
 
 
 
Figure 1.2. Cellular architecture of OE. A schematic representation of mouse OE is shown, the apical 
layer is populated by sustentacular cells; the intermediate layer is composed by mature and immature 
olfactory sensory neurons and the basal layer is characterized by the presence of globose and horizontal 
basal cells, olfactory neural progenitors and immediate neuronal precursors.  
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The basal layer of the OE is composed by globose basal cells (GBCs), horizontal 
basal cells (HBCs) and olfactory neural progenitors. GBCs and HBCs have been 
characterized as multipotent stem cells, able to generate OSN progenitors during both 
embryonic and adult neurogenesis (Jessica H. Brann and Firestein 2014). 
OSNs, which occupy the middle layer of the OE, are bipolar neurons projecting a 
single dendrite with a thickened ending (the olfactory knob) that extends to the 
epithelial surface. The olfactory knob contains non-motile sensory cilia where ORs are 
expressed to detect odors. A unique axon penetrates the skull through the cribriform 
plate and synapses in the olfactory bulb. OSNs have a short average life-time (about 70 
days) and are replaced periodically throughout the lifespan of an individual (Sultan-
Styne et al. 2009). 
Sustentacular cells (SCs) compose the apical layer of OE that is in contact with the 
air flow circulating through the nasal cavities. SCs are functionally similar to glial cells 
in the central nervous system. 
1.1.2 OE neurogenesis 
Different works have demonstrated that neurogenesis is not restricted to embryonic 
development, but persists in specific areas into adulthood (Graziadei and Graziadei 
1979; Altman 1962). 
There are three main neurogenic areas in the nervous system: the subgranular zone, 
which generates new granule cells to the dentate gyrus of the hippocampus; the 
subventricular zone (SVZ), which provides new interneurons to the OB; and the OE, 
which supplies new OSNs that innervate OB. In the OE, the renewal ability is likely a 
protective mechanism to preserve the sense of smell over time, given that the OE is 
directly and continuously exposed to insults coming from the outer environment (Hurtt 
et al. 1988). 
Embryonic origin of OE 
In OE the first signs of cellular differentiation can be observed at embryonic day 10 
(E10), when first embryonic stem cells and developing OSNs are detected (Murdoch 
and Roskams 2008). OSN dendrites are observed at E11 when the first OE and OB 
connections are reported. Indeed, OE-OB synaptogenesis takes place between E11 and 
Introduction 
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E15. Interestingly, the first OR expression predates OE-OB synaptogenesis, since it has 
been reported as early as E11 (López-Mascaraque and de Castro 2002). 
Adult neurogenesis 
GBs and HBCs are responsible for generating OSNs during the late embryonic to 
postnatal stages. Stem cell populations generate Ascl1+ progenitors which in turn give 
rise to Neurogenin-1 and NeuroD1+ immediate neuronal precursors (INPs) (Packard et 
al. 2011; Suárez, García-González, and de Castro 2012). INPs differentiate in GAP-43+ 
immature OSNs that finally reach maturity once expressing olfactory marker protein 
(OMP) (Figure 1.3). An essential requirement for OSNs maturation is the stable 
expression of ORs. Indeed, ORs are expressed not only on the cilia of OSNs, where 
they are involved in detecting odors, and at the axon termini, where they direct the 
neuronal innervation pathway towards the OB. 
 
Figure 1.3. Schematic representation of OSNs differentiation. OSN differentiation process is shown. 
For each cell type, peculiar expressed genes are shown. 
 
1.1.3 OR genes: structure and distribution in the genome 
In 1991 Linda Buck and Richard Axel identified in rats an extremely large multigene 
family of transmembrane proteins that were hypothesized to be ORs on the basis of 
their typical expression pattern, restricted to the OE. Further studies confirmed that OR 
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genes form the largest multigene family ever found in vertebrates (X. Zhang and 
Firestein 2002).  
Each OR gene includes an intronless coding region of about 1 kb, preceded by 
upstream regulatory exons and terminating with a polyadenylation signal. The number 
of 5’ non-coding exons ranges between 1 and 4. 
In mouse there are about 1200 OR genes, organized into 27 gene clusters dispersed 
throughout the genome and represented on all chromosomes except chromosomes 12 
and Y. 20% of the total mouse OR genes are pseudogenes, which do not code for 
functional OR proteins. In humans there are 950 ORs, distributed in 100 locations 
throughout the genome, and 60% of them are pseudogenes (X. Zhang and Firestein 
2002). This size difference between mouse and human repertories can be due to human 
development of trichromatic color vision that is very powerful in detecting 
environmental signals. It is likely that olfaction has become less important for primates 
confronted to other dichromatic mammalian species. 
1.1.4 OR gene choice: monogenic and monoallelic expression 
Each mature OSN expresses only one OR gene from the entire genome repertoire, 
according to a peculiar genomic feature which can be summarized as “one-receptor-
one-neuron rule”. Moreover, in a given OSN a specific OR is expressed only from a 
single allele, and OSNs expressing the maternal or paternal allele coexist mosaically in 
the OE.  
Expression of one OR gene per OSN does not mean that each OR gene is expressed 
in the same number of neurons. Conversely, counts of OSNs expressing a given OR 
gene in mouse or rat give variable results from gene to gene (Mombaerts 2004; 
Rodriguez-Gil et al. 2010). Moreover, unequal tissue RNA levels across the OR 
repertoire can vary by almost 300-fold (Young et al. 2008). 
Interestingly, once selected by the OSN, the same OR is expressed both on the 
dendritic cilia and on the axon termini of the neuron. Axons from different OSNs that 
express the same OR gene coalesce into one or a few glomeruli of the OB. Therefore, 
each selected OR is involved in sensing odors and a main actor in directing OSN 
innervation pattern towards the OB. Therefore, a stable OR expression is essential for 
both the differentiation and integration of the mature OSN into the functional olfactory 
network. 
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The OR choice is supposed to occur at the level of the olfactory neural progenitor 
cells which then differentiate, first in an immature neuron and finally in a mature OSNs 
which innervates the OB (Figure 1.3). 
So far the molecular mechanisms underlying the OR transcriptional regulation are 
almost completely unknown. Many hypotheses and models have been proposed in the 
last twenty years to explain how each OSN selects the right OR allele.  
As already mentioned, OR expression has been reported as early as E11, before OE-
OB synaptogenesis. Therefore, even at the earliest embryonic ages, OSNs expressing 
the same OR have restricted zonal/regional expression patterns, suggesting that 
retrograde signals from the OB do not influence OR gene choice in the OE (López-
Mascaraque and de Castro 2002). 
It is well accepted that different elements and events are involved in the selection of 
a given OR, including the gene coding sequence, short DNA sequences upstream of OR 
coding sequences, locus control regions (LCR)-like conserved elements, and feedback 
signals given by the expression of a full-length OR protein (Serizawa et al. 2003). 
Here, we summarize the state of the art about the molecular mechanisms involved in 
ORs transcriptional regulation.  
Different DNA sequences were described acting as proximal and distal OR 
regulatory sites. Homeodomain and O/E-like binding sites were identified in the 
proximal upstream regions of some ORs (Hirota and Mombaerts, 2004) (Rothman et al. 
2005). 
Additional sequences, called P and H elements, were described to act as distal 
enhancer regulating the probability of OR gene choice differentially across their cluster 
(Khan, Vaes, and Mombaerts 2011). 
Moreover, the chromatin state has been demonstrated to have central role in OR 
regulation. In particular, singular OR expression can be initiated by lysine demethylase 
1 (LSD1), which catalyzes an epigenetic switch that allows localization of the active 
OR allele to a specific nuclear subdomain distinct from inactive ORs (Clowney et al. 
2012) (Lyons et al. 2013) (Tan, Zong, and Xie 2013). 
Recently, Dalton and colleagues hypothesized that, following the OR gene choice, 
the unfolded protein response (UPR) could serve as a molecular signal that triggers a 
negative feedback to down regulate LSD1(Dalton, Lyons, and Lomvardas 2013). 
Therefore, the so-called “one OSN-one OR rule” is enforced by a negative feedback 
signal that requires functional OR expression. 
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Historically, one of the major limitations to the understanding of transcriptional 
regulation for OR genes has been the lack of a clear characterization of OR promoters 
and transcription start sites (TSSs). In 2012 a NanoCAGE (a cap analysis of gene 
expression protocol adapted for low amounts of input RNA) experiment on RNA from 
mouse OE identified TSSs of 87% of the OR genes giving an important contribution to 
reveal genomic features which can participate to OR expression choice (Plessy et al. 
2012). 
Nevertheless, the molecular mechanisms able to determine which OR allele is 
chosen, among the 2400 different ones available, remain unclear. 
In this work we hypothesized that transposable elements could be involved in the 
choice of the OR gene, in particular LINE-1-associated structural variations in the locus 
of active OR genes could have a role in determining the receptor expression. 
 
1.2 Transposable elements 
Transposable elements (TEs) comprise a multitude of repetitive DNA sequences with 
the ability to mobilize and change locations in the genome (Kazazian 2004). They were 
first discovered in maize plants in the mid-1940 but they are generally present in the 
genomes of prokaryotes and eukaryotes. Initially they were considered junk DNA and 
selfish DNA parasites due to their lack of a clear functional role and ability to replicate 
independently and therefore being a potential threat towards genomic integrity 
(Fedoroff 2012). 
Given the discovery that TEs occupy around 40% of mouse genome (Bourc’his and 
Bestor 2004) (Walsh, Chaillet, and Bestor 1998) (Mouse Genome Sequencing 
Consortium et al. 2002), the concept of junk DNA is not acceptable and the idea has 
shifted towards understanding their functional role. Even if the modern view of TEs is 
still controversial it is now evident that they still participate in shaping genomes, 
influencing gene expression and contributing to tissue-specific transcriptional programs, 
in particular as enhancer-like elements and regulator of chromatin structure (John L. 
Goodier and Kazazian 2008) (Bodega and Orlando 2014). 
According to their mechanism of mobilization, TEs can be divided in two main 
groups: class II TEs, or DNA transposons, that move throughout the genome using a 
“cut and paste” mechanism, and class I TEs, or retrotransposons, that multiply 
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themselves in the genome via a RNA intermediate, with a “copy and paste” mechanism 
(Figure 1.4) (Wicker et al. 2007). 
 
Figure 1.4. Classes of TEs found in mammalian genomes. Different types of TEs (DNA transposons; 
ERV, endogenous retrovirus; LINE-1, long interspersed element class 1; SINE, short interspersed 
element) are shown. Fractions of the human and mouse genomes occupied by each TE type is represented 
as percentage on the right. IR, inverted repeat; UTR, untranslated region; EN, endonuclease; RT, reverse 
transcriptase; LTR, long terminal repeat; ORF, open reading frame (Garcia-Perez, Widmann, and Adams 
2016). 
1.2.1 DNA transposons 
During mobilization DNA transposons are first excised from their original location 
as double-stranded DNA and then reinserted elsewhere in the genome. DNA 
transposons structure is characterized by a transposase encoding gene included between 
the inverted terminal repeats (ITRs) (Figure 1.4). The autonomously encoded 
transposase is able to catalyze both the excision and integration of the repetitive 
element: it recognizes ITRs and binds them, then it “cuts” the DNA transposon and 
“pastes” it into a new genomic site, giving rise to a non-replicative mechanism where 
the DNA transposon is moved to a new location but no transposon copies are generated. 
During the insertion, the target site DNA is duplicated at both ends of the transposable 
element, forming the so called target site duplications (TSD), which are unique for each 
different DNA transposon (Munoz-Lopez and Garcia-Perez 2010). 
The classification of DNA transposons is commonly based on the sequence, the ITRs 
and /or the TSDs. Among the subclass I there are: Tc1/mariner, PIF/Harbinger, hAT, 
Mutator, Merlin, Transib, P, piggyBac and CACTA. In the Subclass II there are 
Helitron and Maverick transposons. The most widespread TE family in nature is the 
Tc1/mariner that is present in diverse taxa as rotifers, fungi, plants, fish and mammal 
(Lopez and Garcìa, 2010). Currently there are no active DNA transposons in mammals, 
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and recent computational analyses indicated that their activity ceased in the primate 
lineage at least 37 million years ago (Pace and Feschotte 2007). At present they 
comprise approximately the 3% of the human reference genome (Beck et al. 2011) and 
the 4% of the mouse genome (Keane et al. 2014). 
1.2.2 Retrotransposons 
Retrotransposons constitute 42% of the genome and duplicate via a RNA 
intermediate using a “copy-and-paste” mechanism. Retrotransposons are first 
transcribed into RNA, then retrotranscribed and inserted in a new genomic location. 
With this mechanism, a second novel insertion is created, while the original transposon 
is preserved. 
Depending on whether they are able to encode the transposition machinery or not, 
retrotransposons can be classified in autonomous and non autonomous. Autonomous 
retrotransposons encode for the proteins necessary to their own retrotransposition. 
Non-autonomous elements include processed pseudogenes and short interspersed 
nuclear elements (SINE), which overall constitute 13% of human genome. In order to 
be mobilized they need retrotransposition proteins to be encoded by the autonomous 
elements. 
 Among autonomous elements a further classification can be made into elements 
which possess Long Terminal Repeats (LTR) and elements without LTRs (non-LTR 
retrotransposons). The most prominent members of the first category are the 
endogenous retroviruses (ERVs) which comprise approximately 8% of the genome and 
the mouse intracisternal A-particles (IAPs). 
Non-LTR retrotransposons account for 21% of the genome and comprise Long 
Interspersed Nuclear Elements (LINE), which can be further divided into three 
subfamilies LINE1, LINE2 and LINE3. Among these three, only LINE1 or LINE-1 
elements are currently active in humans and mice (Lee et al. 2012). For this reason, we 
will focus only on this subfamily in the following paragraphs. 
Long interspersed nuclear elements (LINE-1)  
LINE-1s are highly abundant and constitute approximately 17% of the human 
genome and 19% of the mouse genomes, respectively (Mandal and Kazazian, 2008). 
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Most LINE-1s are retrotransposition-defective due to 5’ truncation, internal 
rearrangements or point mutations that disrupt their open reading frames. Among the 
5000 LINE-1 full length copies present in the human genome, roughly 80-100 elements 
contain two intact open reading frames and are considered retrotransposition-competent 
(Beck et al., 2011). 
By comparison, the mouse genome is estimated to contain about 11,000 LINE-1 full 
length copies, among which at least 3000 are still active (J. L. Goodier 2001). 
Retrotransposition-competent LINE-1s encode the machinery necessary to support 
their own replication through an RNA intermediate. They are 6 kb in length and contain 
a 5’ untranslated region (UTR), two open reading frames (ORF1 and ORF2) and a 
3’UTR followed by a polyadenilation signal (AATAAAA) (Figure 1.5). 
The 5’UTR region contains an internal RNA polymerase II promoter and several 
binding sites for regulatory elements such as a CpG island, two SRY box binding 
domains, a YY-box transcriptional initiation start site and a RUNX binding site. 
Antisense promoter activity (ASP) located at the LINE-1 5’UTR has been extensively 
demonstrated (Speek 2001) 
The ORF1 and ORF2 encode for proteins necessary for retrotransposition activity. 
ORF1 encodes a 40kDa protein (ORF1p) with RNA-binding activity. It contains a 
highly-conserved C-terminal region, an RNA binding motif and a less-conserved N-
terminal α-helical domain. On the other hand, ORF2 encodes a 150 kDa protein 
(ORF2p) with three conserved domains, an N- terminal endonuclease (EN) domain, a 
central reverse-transcriptase domain (RT) and a C-terminal zinc knuckle-domain. The 
LINE-1 endonuclease (EN) domain is responsible for the DNA double strand break 
(DSB) at the insertion target site, whereas the RT activity generates the cDNA copy of 
LINE-1 to be inserted into the new genomic location (Beck et al., 2011) (Ostertag and 
Kazazian 2001). 
Human and mice share the same structure of the LINE-1 gene, apart from the 
promoter region at the 5’UTR. Indeed, the 5’ UTR region of rodents is characterized by 
the presence of repeated conserved monomers of about 200bp followed by a short non 
monomeric region. The variability at the 5’UTR region can reside in differences in both 
number and sequence of the monomers. 
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Figure 1.5. Structure of the mouse LINE-1. The 5’UTR region is composed of a variable number of 
monomers (  ̴ 200 bp, red triangles) having promoter activity. Polymorphisms are present at the 3’UTR, 
here indicated with red vertical axis. ORF1 and ORF2 open reading frame are indicated. E =endonuclease 
domain; RT= retrotranscriptase domain; pA= polyadenylation signal; TSD= target site duplication. 
Adapted from (Mears and Hutchison 2001). 
 
Depending on the 5'UTR monomeric organization murine LINE1s are divided into 
different sub-classes. Phylogenetically all mouse LINE-1 elements seem to derive from 
a common ancestor which has spawned several subfamilies differing in their 5’ end 
region: V, A, Tf and Gf subtypes (J. L. Goodier 2001) 
The V family has no identifiable monomers and is supposed to be the oldest and 
inactive subfamily.  
The A family members have a monomeric structure at their 5’ region and contain 
about 6500 full length elements. A subset (900) of A elements is supposed to be 
retrotransposition-competent (or active) because they contain intact ORF1 and ORF2 
and are transcribed, although their retrotransposition capacity has never been directly 
assayed.  
The Tf and Gf families, derived from a common ancestor (F-family), have different 
monomeric structure at the 5’UTR and contain a large number of transposable elements. 
The Tf  type has 1800 active elements among 3000 full length members, whereas the 
most recently discovered Gf type includes 400 active elements among 1500 full length 
members (Goodier et al., 2001). In vitro experiments which tested the activity of 
various regions of the mouse Tf 5’UTR have revealed that the promoter activity lies 
within the monomers and therefore the promoter activity seems to be enhanced 
proportionally to the number of monomers (Ostertag and Kazazian, 2001). 
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1.2.3  Molecular mechanism of LINE-1 retrotransposition 
 
Figure 1.6. LINE-1 retrotransposition cycle. The full-length active LINE-1 RNA is first transcribed in 
the nucleusby cell host factors (HF) (1) and transported to the cytoplasm where ORF1p and ORF2p are 
translated (2). These proteins preferentially bind in cis to their encoding mRNA, generating a 
ribonucleoprotein particle (RNP), which is shuffled back into the nucleus (3). The EN activity of ORF2 
protein generates a single strand (SS) break in genomic DNA that is used by the ORF2-RT activity to 
generate the first-strand cDNA (4) (red arrow). How second strand synthesis occurs is not well 
understood. New LINE-1 insertions are often flanked by TSDs (blue or green arrowheads) and are also 
often 5′-truncated (not shown). HF, host factor involved in the retrotransposition process. (Adapted from 
Garcìa et al., 2016). 
 
During retrotransposition, the LINE-1 sequence is transcribed by RNA polymerase II 
starting from its own internal promoter, leading to the generation of a bicistronic mRNA 
(Figure 1.6-step1). This mRNA molecule has a polyA tail that can be encoded by its 
own weak but functional polyadenylation signal, or by a signal present in the 
downstream genomic sequence, in this case leading to the so called LINE-1-mediated 
3’- transduction. It is still not known whether a 7-methylguanosine cap is added to 
LINE-1 transcripts, while it is clear they do not contain introns (Ostertag and Kazazian, 
2001). 
The next step involves the transport of the LINE-1 RNA molecule to the cytoplasm, 
where the ORF1 and ORF2 sequences are translated into proteins (Figure 1.6-step2). 
The shuttling mechanism involved in the process is still unknown. 
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In the cytoplasm,  multiple copies of ORF1p and only few copies of ORF2p bind 
with the LINE-1 RNA molecule, creating a stable ribonucleoprotein complex (RNP) 
(Figure 1.6-step3) (Kulpa and Moran 2006)(Beck et al., 2011).  
 
 
 
Figure 1.7. Comparison between TPRT and ENi LINE-1 insertions. (A) TPRT-mediated LINE-1 
insertion. LINE-1 endonuclease (red arrowhead) cut first strand DNA at the 5’-TTTT/A-3’ consensus (red 
box) and allows LINE-1 mRNA (blue line) to anneal to genomic DNA using its poly(A) tail. Reverse 
transcriptase activity of LINE-1 ORF2 (oval) synthesizes LINE-1 cDNA (purple line) using LINE-1 
mRNA as template and 3’OH from nicked genomic DNA as primer. Second-strand cleavage (blue 
arrowhead) occurs 7–20 bp downstream from first cleavage site, creating nicks which are repaired to form 
TSDs (blue dotted boxes). The insertion process is completed by the attachment of the LINE-1 cDNA and 
synthesis of the second strand. (B) Schematic representation of ENi mechanism. The creation of a 
genomic double-strand break (red thunderbolt) is followed the attachment of free-floating LINE-1 mRNA 
(blue line) to newly separated ends using small complementary sequence. Finally the gap may be filled in 
by DNA synthesis by either the LINE-1 RT, cellular repair polymerases or both (S. K. Sen et al. 2007). 
 
This complex, through a mechanism that has not yet been clarified is carried back 
into the nucleus (Figure 1.6-step3). Here two different LINE-1 integration mechanisms 
can be mediated (Figure 1.6-step4-5): the canonical target primed reverse transcription 
(TPRT) or the endonuclease-independent (ENi) retrotransposition (Viollet, Monot, and 
Cristofari 2014) (Figure 1.7). 
The target primed reverse transcription (TPRT) consists of a coupled reverse 
transcription/integration process (Morrish et al. 2002). During TPRT, ORF2p 
endonuclease activity produces a single-strand nick in the genomic DNA preferentially 
at the consensus sequence 5′-TTAAAA/3′-AATTTT. The ORF2p reverse transcriptase 
activity, priming the reaction within the polyA tail, extends the free 3′-OH group using 
the LINE-1 RNA as a template (Viollet, Monot, and Cristofari 2014). After that, the 
second strand at the integration site is cleaved and used to prime the synthesis of the 
cDNA second strand. The typical hallmarks of this TPRT-derived integration 
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mechanism include the target site duplications (TSDs), 7-20 bp sequences present at 
each end of the new LINE-1 element, and a dA-rich tail of variable length (Cordaux and 
Batzer 2009). Another feature of this integration process is the fact that the majority of 
the newly inserted LINE-1 elements are 5’ truncated, and therefore unable to 
retrotranspose any longer. This truncation may be caused by an inefficiency of the 
reverse transcriptase in the polymerization process of the new cDNA copy, or by the 
activity of a cellular RNAse H, reflecting a possible attempt by the host defense 
machinery to protect the genomic integrity (Ostertag and Kazazian, 2001; Beck et al., 
2011).  
In the endonuclease-independent (ENi) retrotransposition process, at the level of a 
pre- existing double-strand break, LINE-1 mRNA molecules can attach to the 
protruding ends using small stretches of complementary bases without the need for a 
further endonuclease cleavage. At this point the LINE-1 reverse transcriptase, the host 
repair polymerase or both synthetize the missing DNA bases, leading to a LINE-1 
integration that lacks the structural features of the TPRT-mediated insertion. The typical 
hallmarks of this alternative process are unusual structures caused by LINE-1 
integration at atypical target sequences, LINE-1 truncations predominantly at the 3′ 
ends and lack of TSDs (Morrish et al., 2002). LINE-1 integration mediated by the ENi 
mechanism has been observed at the level of telomeres although it is a significantly less 
efficient process, rarely found in vivo (Babushok 2005). 
1.2.4 LINE1 mobilization effects 
Host genomes use different mechanisms to minimize potential consequences of 
transposons mobilization among which DNA methylation is one example. Nevertheless, 
LINE-1 retrotransposition events are able to remodel the structure of the genome with 
different mechanisms. 
Insertional mutagenesis 
This is the first described genomic modification induced by LINE-1 insertions. In 
this mechanism, LINE-1 element inserts in the exon of a gene, inducing an interruption 
of the coding sequence (Kazazian et al., 1998). 
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3’ and 5’transduction 
As previously mentioned, the polyadenylation signal present at the 3’UTR of the 
LINE-1 element is functional but weak, and therefore often substituted by downstream 
stronger signals. This mechanism, the so called “3’ transduction”, causes the 
transcription, and possibly the retrotransposition of a segment of genomic sequence 
present at the 3’ of the LINE-1 element. 3’ transduction events were reported in mouse 
and human, where 15 out of 66 uncharacterized LINE-1 sequences were demonstrated 
to carry 3’genomic sequences with an average length of 207 bp (J. L. Goodier 2000). 
Usually shorter and less common is the 5’ transduction that can be identified only at the 
level of full length LINE-1 elements: in this case the transduction occurs when the 
LINE-1 element is transcribed starting from an upstream promoter, causing the 
retrotransposition of a segment of genome upstream to the LINE-1 5’UTR (Beck et al., 
2011). 
Heterochromatinization 
In 1998, after the description of chromosome X inactivation (also called lyonization 
process), it was hypothesized for the first time a possible involvement of LINE-1 
elements in the heterochromatinization of the X chromosome (Lyon 1998).  
Only recently it has been demonstrated that actually LINE-1 elements participate 
during the process in two steps: silent LINE-1s create a heterochromatic compartment 
in which genes are recruited, while a subset of active and expressed LINE-1s help in X- 
chromosome inactivation propagation to those genes that are prone to escape (Chow et 
al. 2010). 
LINE-1-associated genomic deletions 
Genomic deletions can be generated by LINE-1s at 2 distinct stages of the 
retrotransposon life cycle: (i) at the time of insertion of the element at a new genomic 
locus via either classical endonuclease-dependent or non-classical endonuclease-
independent retrotransposition, and (ii) at a post-insertional stage, by re-combination 
between LINE-1 elements potentially inserted in the genome for a long time. This latter 
mechanism is part of the interaction between TEs and DNA-DSB repair systems which 
will be discuss in detail in paragraph 1.4.1. 
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Deletion generated at the insertion site 
When a new LINE-1 element inserts in the genome according to the canonical 
endonuclease-dependent TPRT, it can generate either small duplications or small 
deletions of the target site nucleotides depending on endonuclease cleavage.  
Although there is a clear LINE-1 EN consensus “bottom strand” cleavage site (5′-
TTAAAA/3′-AATTTT) and variants of the sequence (Jurka 1997), it has been 
demonstrated that there is little or no target site preference for top strand cleavage. 
According to this model, top strand cleavages downstream of the initial endonucleolytic 
nick ultimately will lead to the generation of TSDs. By contrast, top strand cleavages in 
direct opposition or upstream of the initial endonucleolytic nick will result either in 
conservative insertions or the generation of small deletions.  
Simple modifications of this model can produce additional rearrangements like 
LINE-1 chimeric elements and large deletions (Gilbert, Lutz-Prigge, and Moran 2002). 
In cultured human cells it has been observed that the 10% of the integrations 
mediated by an engineered LINE-1 element were characterized by genomic loss, as also 
observed in the human and chimpanzee genomes (Beck et al., 2011). 
1.2.5  Where and When do LINE-1s mobilize? 
LINE-1 retrotransposition in germline and during embryo development 
Where and when LINE-1 elements are expressed and retrotransposed during the life 
of an organism is a fundamental question to address.  
Previously LINE-1 retrotransposition was believed to occur only in the germline 
during gametogenesis and the accumulation of LINE-1 elements in the genome during 
evolution was considered a clear sign of heritable retrotransposition. LINE-1 
mobilization during these developmental phases can be linked to the typical pattern of 
DNA hypomethylation observed in the cells of the germline, fundamental for the 
epigenetic reprogramming that occurs during germ cell specification (Smallwood and 
Kelsey 2012). Indeed, it has been demonstrated that germ cell populations of mice 
lacking de novo methyltransferase 3-like (Dnmt3L) present higher concentrations of 
LINE-1 transcripts (Bourchis and Bestor, 2004). Recently, the impact of LINE-1 
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retrotransposition on viability and quality of fetal oocytes in mice or fetal oocyte 
attrition (FOA), has been described (Malki et al. 2014). 
However, this idea is slowly changing since several lines of evidence, collected using 
different models of LINE-1-transgenic mice and rats, are showing that a burst of LINE-
1 retrotransposition events might occur also in the soma, especially during early stages 
of embryogenesis (Kano et al. 2009). These somatic retrotransposition events are not 
incorporated into germ cells, so they are not heritable and will not accumulate in the 
genome of all cells.  Clearly, these events provide sources of genomic diversity within 
distinct somatic cells of an individual, generating somatic mosaicism in a particular 
tissue (Vitullo et al. 2012). 
High concentrations of LINE-1-mRNA was also present in mouse embryos (Kano et 
al. 2009. It was demonstrated that probably LINE-1 mobilization and integration occur 
probably more often during embryogenesis than in the germline. In particular, by using 
an LINE-1 transgenic mouse model, high levels of LINE-1-mRNA expression were 
detected, both in germ cells and in embryos, particularly at pre-implantation stages and 
later on at E10.5 (Kano et al. 2009).  
Moreover, it has been recently demonstrated that the RT protein encoded by LINE-1 
has a fundamental role during the early embryonic development: by incubating mouse 
zygotes with the non-nucleoside RT inhibitor nevirapine or microinjecting murine 
zygotes with morpholino-modified antisense oligonucleotides against the LINE-1 5’end 
region, they observed an arrest of development at the two- and four-cell stage (Pittoggi 
et al., 2003). 
However, the frequency and specific timing of retrotransposition events in early 
embryos and during gametogenesis remain to be determined.  
Interestingly, further evidence demonstrated that LINE-1 retrotransposition is not 
limited to germ line and embryogenesis but new LINE-1 insertions can occur also in 
tumors (Moran et al. 1996) (Ostertag 2000) and in the brain (Muotri et al. 2005; Muotri 
et al. 2010; Coufal et al. 2009; Erwin et al. 2016). 
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Figure 1.8. Consequences of somatic retrotransposition events during embryogenesis. Somatic 
retrotransposition can happen at any time during embryogenesis. Retrotransposition events that occur in 
early pluripotent progenitor cells will result in somatic mosaicism: these unique cells will contribute to all 
tissues of the body of the individual, including the germ line. Somatic retrotransposition that happens 
after germ-layer specification and organogenesis, however, results in tissue-specific insertions that are not 
hereditary. Adapted from (Erwin et al., 2014).  
 
Somatic LINE-1 retrotransposition in the nervous system 
Multiple levels of complexity characterize the intricate cellular network in the 
nervous system. Here, besides cells of different subtypes there are many cells that, 
although belonging to the same subtype, display different structural and functional 
features. 
 
 
Figure 1.9. Consequences of somatic retrotransposition events in the brain. Blue and red nuclei in 
represent unique genomes as result of somatic retrotransposition in neuronal progenitor cells. Adapted 
from (Erwin et al., 2014). 
 
Epigenetic regulation, alternative splicing and post-translational modifications are 
some of the factors involved in the determination of these diversities. The discovery of 
neurons with different genotypes, the so called somatic mosaicism, makes the nervous 
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system more complex than ever thought (Figure 1.9) (Erwin, Marchetto, and Gage 
2014). 
Muotri and colleagues in 2005 demonstrated that both endogenous and engineered 
LINE-1 elements can retrotranspose in the mammalian brain (Muotri et al., 2005). 
LINE-1 transcripts were detected in neural progenitor cells (NPCs) and new LINE-1 
insertions can accumulate in NPCs in mouse models of human LINE-1 
retrotransposition and in human NPCs in culture (Coufal et al., 2009) (Muotri et al., 
2005). This selective expression of LINE-1 in NPCs compared to other tissues seems to 
be explained by a change in methylation level of LINE-1 promoter in brain cells 
(Coufal et al; 2009). 
Moreover, the transcription factor SOX2 seems to repress LINE-1 transcription in rat 
adult hippocampal NPCs. Indeed, during neuronal differentiation, the low expression of 
SOX2 corresponds to a higher LINE-1 transcription and retrotransposition (Muotri et 
al., 2005).  
Recently, single-cell genomics-based studies coupled with next-generation DNA 
sequencing have allowed researchers to demonstrate that mosaic genomes are a 
peculiarity of the human brain (Baillie et al. 2011) (Erwin et al. 2016) (Evrony et al. 
2012)(Upton et al. 2015), although there is an ongoing debate about the frequency of 
retrotransposition in this tissue (Evrony et al. 2015)(Richardson et al. 2014).  
In human brain LINE-1 retrotransposition has been clearly characterized only in 
hippocampus (Upton et al., 2015) but little is known about the level of 
retrotransposition in other brain areas. Recently, Macia and colleagues demonstrated 
that both LINE-1 expression and retrotransposition can occur even in post-mitotic 
differentiated neurons (Angela Macia et al. 2016). 
 
1.3 TEs and gene expression 
During the last 15 years, several works have been investigating how 
retrotransposition can modulate gene expression. In particular, great attention has been 
posed on the nervous system, where LINE-1s have been shown to be able to mobilize 
and create somatic mosaicism. 
1.3.1  LINE-1s function as portable promoters 
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Newly inserted LINE-1 elements can affect somatic genomes by modulating RNA 
abundance changing the expression of messenger RNA (mRNA) and/or non-coding 
RNA (ncRNA). Gene expression levels are modulated differently depending on where, 
and in which orientation, a LINE-1 element inserts into the gene (Viollet et al., 2014). 
For example, no effect on transcript levels is reported if LINE-1 elements are inserted 
into an intron in the antisense orientation, whereas a substantial decrease in transcript 
abundance is observed when a LINE-1 element is inserted in sense orientation (Viollet 
et al., 2014). 
LINE-1 elements contain both a sense and antisense Pol II promoter in their 5′UTR 
and ORF1 sequence, respectively, as well as a recently discovered Pol II promoter in 
their untranslated 3′UTR. Bidirectional transcription from the sense and antisense 
promoter can produce chimeric transcripts, non-coding RNA, antisense mRNA or 
double stranded RNA (dsRNA), which can affect gene expression in distinct ways. For 
example, in vitro experiments on human embryonic stem cells demonstrated that the 
antisense promoter can be used as alternative promoter in driving the transcription of 
the genomic sequence upstream to the 5’UTR of the LINE-1 element also in a tissue-
specific way, inducing tissue-specific gene expression of specific genes (Mätlik, Redik, 
and Speek 2006) (A. Macia et al. 2011).  
The promoter in the 3′UTR is in the sense orientation and since the majority of new 
somatic LINE-1 insertions are 5’truncated, it is likely that many newly inserted LINE-1 
sequences still contain the 3′ UTR promoter and may initiate transcription of 
downstream genes (Faulkner et al.,2009).  
DNA methylation and histone modifications are well characterized epigenetic 
mechanisms able to keep LINE-1 transcription under control: when these repressive 
marks are relieved, LINE-1s are activated. Activation of previously silenced 
retrotransposons can cause expression changes at neighboring genes by altering the 
timing or tissue specificity of gene expression. Conversely, retrotransposons are targets 
for DNA methylation, which induces a repressive chromatin structure that can spread to 
coding sequences in their proximity, effectively silencing them (Viollet et al., 2014).  
1.3.2 TEs as tissue specific enhancers 
TEs can regulate gene expression also harboring transcription factor binding sites 
that can act as host gene enhancers in specific tissues or developmental stages. In 
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particular, among LTR elements, ERVs are present in 5-25% of the genomic regions 
bound by the pluripotency-associated transcription factors OCT4 or NANOG in human 
and mouse embryonic stem cells (ESCs). Moreover, in mouse ESCs, ERV elements 
contain the binding sites for the pluripotency-associated transcription factor SOX2 
(Bourque et al., 2008) (Kunarso et al., 2010). 
During brain development SINE elements can act as enhancers for host genes. SINE 
insertions are associated with both ISL1 and Fgf8 genes, involved in motor neuron 
development and brain development respectively (Bejerano et al. 2006) (Sasaki and 
Matsui 2008).  
DNA transposons, even though they no longer mobilize in most mammals, can act as 
enhancer to influence host gene expression. For example, some DNA transposons have 
been shown to act as neocortical enhancers for genes involved in neuronal development 
(Notwell et al. 2015). 
1.3.3 SINEs as regulators of chromosome organization  
TEs can play an important role in influencing the organization of mammalian 
chromosomes, and they are indeed enriched within regions of mammalian genomes that 
bind CTCF. Moreover, in mice SINE B2 elements carry a CTCF-binding motif 
(Bourque et al. 2008)(Schmidt et al. 2012)(Sundaram et al. 2014).  
CTCF is a well characterized protein which can have multiple functions, acting as an 
insulator to block the interaction between an enhancer and a promoter, or to prevent the 
spreading of chromatin domains and as an anchor that assembles chromatin into loops 
or domains allowing the interaction of regulatory elements (Merkenschlager and Nora 
2016). Together with cohesin, CTCF allows developmental long-range enhancers to 
regulate gene expression (Merkenschlager and Odom 2013).  
One example of a SINE insertion that can influence developmental gene regulation 
through effects on chromatin domains occurs during the expression of growth hormone 
(GH) in the developing pituitary. Here the SINE element, in collaboration with cohesin 
elements, is necessary and sufficient to prevent the spreading of repressive chromatin in 
the GH domain (Lunyak et al. 2007). 
1.3.4  LINE-1 in the healthy brain: functional role? 
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It is still an open question whether LINE-1 retrotransposition has a function in the 
brain. LINE-1 elements could act as enhancers or promoters for host genes in the brain 
but at the same time it is also possible that LINE-1 elements are on the way to be 
domesticated by the host genome, like the domestication of DNA transposons in the 
immune system. It has been hypothesized that the RAG1 and RAG2 genes, necessary 
for V(D)J recombination in developing lymphocytes were derived from the Transib 
superfamily of  DNA transposons (Jurka et al. 2005).  
LINE-1 retrotransposition in the brain is potentially mutagenic but LINE-1 de novo 
insertions affecting brain development or function in patients remains to be 
demonstrated.  
Supporting studies show how LINE-1 activity in the healthy brain induce genomic 
rearrangements that could delete genomic regions proximal to genes, but again any 
functional meaning has to be proved (Erwin et al. 2016). In particular Erwin and 
colleagues, using a single cell sequencing approach, observed that somatic LINE-1-
associated variants are composed of two classes: LINE-1 retrotransposition-dependent 
insertions and retrotransposition-independent LINE-1-associated variants (Figure 1.10). 
 
 
Figure 1.10. Representation of two possible LINE-1 associated variants. On the right: a germline-
inherited LINE-1 sequence is transcribed into RNA. The L1 endonuclease and reverse transcriptase 
protein nicks the genomic DNA and reverse transcribes the L1 RNA, resulting in the insertion of a new 
copy of LINE-1 sequence. On the left: LINE-1 endonuclease preferentially cuts a a germline-inherited 
LINE-1 sequence and recombination with a downstream A microsatellite results in a microhomology-
mediated deletion. The A microsatellite region may be nicked by the L1 endonuclease or a fragile site 
within the genome of neural progenitor cells (Erwin et al. 2016). 
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The first class comprises LINE-1 retrotransposition-dependent insertions. The 
second class comprises deletions mediated by LINE-1 endonuclease or other 
mechanism but independent of LINE-1 retrotransposition, indeed no additional inserted 
sequence or TSD flanking regions are found in the deleted sequence. 
In order to discover the mechanism supporting for retrotransposition-independent 
LINE-1 associated deletions the authors first demonstrated that LINE-1 sequences are 
prone to instability since they contain the preferential sequence motif recognized by the 
endonuclease they encode. In particular, the increased expression of LINE-1 
endonuclease during neural differentiation induced DBSs preferentially at LINE-1 loci 
and microhomology-mediated repair system could support the formation of these 
deletions (Erwin et al. 2016). Therefore, LINE-1-associated genomic regions are 
predisposed to somatic CNV in the neurogenic brain areas and this could be one of the 
mechanism explaining the huge neuronal diversity in the nervous system (more details 
about LINE-1 creating DSBs are described in paragraph 1.4). 
1.3.5  Evidence of somatic LINE-1 expression in mouse OE 
(background results) 
The laboratory of S.Gustincich, in collaboration with the group of P. Carninci added 
an important piece of information about LINE-1 expression in neuronal cells types 
outside the central nervous system (Pascarella et al.,2014). A NanoCAGE expression 
analysis in mouse OE revealed massive LINE-1 transcription in OR and VR loci. Both 
full-length and truncated LINE-1 elements were transcribed in OE (Pascarella 2014). 
Several mechanisms have been proposed to explain how LINE-1 could modulate 
transcription of proximal VR and OR genes, including regulation of gene expression via 
LINE-1 5’ and 3’ promoters and LINE-1 as substrate from chromatin modifications. 
Seeding and spreading of heterochromatin could be triggered by the GC-rich region of 
the LINE-1 5’ sense promoter which is a target for methylation (Y. Zhang et al. 2012). 
Conversely, similarly to a mechanism already described for the mouse growth hormone 
locus, demethylation of LINE-1 promoter can drive transcription and induce functional 
chromatin domains which contrast the influence of repressive chromatin modifications 
(Lunyak et al., 2007). LINE-1 transcription can also generate small non-coding RNAs  
and these could be involved in the regulation of local chromatin structure (Olovnikov, 
Aravin, and Fejes Toth 2012). Alternatively, transcriptional activation of LINE-1 in 
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ORs and VRs loci may be involved in the differentiation of olfactory and vomeronasal 
neurons. Both OE and the vomeronasal organ (VNO) are characterized by the ability to 
constantly regenerate throughout the lifespan of an organism (J. H. Brann and Firestein 
2010) and interestingly LINE-1 elements are known to be active during adult 
neurogenesis (Muotri et al. 2005) (Kuwabara et al. 2009). 
We consider NanoCAGE results about LINE-1 expression in OE important 
preliminary data for the project presented in this thesis. NanoCAGE analysis was a 
starting point to go further investigating a possible involvement of LINE-1s in OR 
transcriptional regulation. In particular, we hypothesized that LINE-1-associated 
structural variations (SVs) could have a role in the activation of ORs transcription. 
1.4 TEs, DSBs and SVs: a combination to genomic instability 
Mammalian genomes are characterized by a high density of repetitive elements; 
therefore, it is likely to find them as substrates for genomic SVs at a post-insertional 
stage. 
In fact, the basis of the involvement of repetitive sequences in genomic instability is 
not limited to their abundance in the genomes. If we consider them as pieces of 
homologous sequences it is clear that they have the ability to alter those DNA repair 
processes which rely on homologous recombination, thus resulting in genomic 
rearrangements.  
1.4.1 TEs and DNA-DSBs repair systems 
The mechanisms according to which TEs, along with DSBs repair systems, can lead 
to genomic structural variations are reviewed in detail in the work of Hedges and 
Deininger (Hedges and Deininger 2007). Here we report some representative examples. 
TEs can cause genome instability, serving as by-product of those double-strand break 
(DSB) repair processes which rely on sequence homology. The DNA-damage response 
(DDR) enables the cells to sense DSBs, propagate DNA damage signals, and activate 
signaling cascades that subsequently activate a multitude of cellular responses, until the 
resolution of the lesions. DDR is characterized by the early phosphorylation of the 
H2AX histone at the site of DSB, which can recruit different repair proteins.  
Two DNA-damage repair mechanisms which need tracts of sequence homology are 
homologous recombination repair (HRR) and single strand annealing (SSA).  
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HRR involves the use of hundreds of base pairs of sequence homology, resulting 
error-free repair (Johnson 2000). This pathway is mostly active during the late-S and G2 
phases where sister chromatids are available (Haber 2000) (Figure 1.11). Although 
sister chromatids are the most common template, interspersed TE sequences can offer 
alternative non-allelic homologous sequence on which the invading strand can anneal 
(Shurjo K. Sen et al. 2006). In this particular case the mechanism is called non allelic 
homologous repair (NAHR) (Figure 1.11). Different structural variations, deletions, 
insertions, and inversions, usually referred to as copy-number variations (CNVs) can be 
created as result of NAHR, depending upon the relative position of the non-allelic 
sequences involved. Some possible TE-associated CNVs are represented in Figure 1.11.  
 
 
Figure 1.11. Non allelic Homologous Recombination events among TEs. Three of several possible 
CNV rearrangements resulting from non allelic recombination are shown. In the first instance, 
misalignment of sister chromatids during recombination or DNA repair yield insertion and deletion 
mutations. In the second instance, recombination between two homologous TEs in direct orientation on 
the same physical chromosome results in an inversion of the intervening sequence. In the third image, 
alignment with a non homologous chromosome results in the translocation of chromosome arms.  
 
The other repair mechanism based on homologous recombination is SSA. This 
pathway is active when a DSB occurs within a pair of repetitive sequences with the 
same strand orientation (direct repeats). During SSA, sequences on both sides of the 
DSB are cleaved allowing homologous sequences close to the exposed ends to associate 
and ligate (Figure 1.12) (Pâques and Haber 1999). Usually the homologous sites are 
located close to the break, in order to reduce the genetic loss. Usually such homology 
between sequences in close proximity is found in regions enriched for repetitive 
elements. 
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Figure 1.12. Single Strand Annealing (SSA). In the SSA model, the 5' ends surrounding the breakage 
region are resected, exposing adjacent homology. The homologous strands anneal with each other and are 
ligated, resulted in the deletion of resulted sequence. 
1.4.2 Interspersed repeats are hotspot for LINE-1 endonuclease 
(LINE1-EN) cleavage 
Recent evidence suggests TEs involvement in genomic instability mediated by 
LINE1-EN at a pre-insertional stage: overexpression of LINE-1 endonuclease has been 
demonstrated to play a role in generating endogenous DSBs in human cells (Gasior et 
al. 2006). Moreover, typical TSDs flanking the new inserted LINE-1 contain part of 
LINE1-EN consensus. They can therefore represent preferred hotspots for new EN 
cleavage generating genomic rearrangements possibly mediated by the recombination 
repair mechanisms previously described  (Tremblay, Jasin, and Chartrand 2000). 
Finally, the protein kinase ATM, a crucial protein in many DNA repair signaling 
processes, was demonstrated to be involved in LINE-1 retrotransposition mechanism 
(Gasior et al. 2006), thus suggesting an additional correlation between LINE-1 and 
DNA-DSBs repair systems. 
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1.4.3 The histone -H2AX as marker of DSBs 
Genome stability is a condition required for the fitness of all living organisms. One 
threaten to this stability can be identified in DNA DSBs which are among the most 
cytotoxic DNA lesions (E. P. Rogakou et al. 1998). 
When DNA damages are not properly repaired they can lead to genetic mutations, 
chromosome rearrangements, or even to cell apoptosis. The phosphorylation of H2AX 
histone (variant of the H2A histone), on the C-terminal residue (Ser139), is one of the 
earliest molecular events in response to DNA double-strand breaks (DSBs). The 
phosphorylated H2AX histone (-H2AX) is a crucial cellular signal for the subsequent 
recruitment of the DNA-damage repair protein machinery (E. P. Rogakou et al. 1998). 
Therefore, -H2AX can be a suitable marker for investigating the presence and the 
genomics localization of DSBs in different organisms and in different tissues of the 
same organism. 
1.4.4 H2AX-mediated response to DNA-DSB  
Histone variant H2AX is a key DDR component. DDR involves many proteins: 
sensors as MRE11–RAD50–NBS1 (MNR) complex and ataxia-telangiectasia mutated 
(ATM); mediators as mediator of DNA damage check-point 1 (MDC1); effectors as 
check-point kinase 1 (CHK1 and CHK2). In response to DSBs, different protein kinases 
such as ATM, ATR or DNA-PKcs can rapidly phosphorylate H2AX. Phosphorylation is 
not the only kind of modification occurring on H2AX. Recent evidence showed that 
during DDR H2AX can also be subject to different modifications such as ubiquitination 
and acetylation. In particular, H2AX monoubiquitination at Lys119/Lys120 residues 
has been demonstrated to be critical for the formation of -H2AX and the recruitment of 
MDC1 to DNA damage sites (Pan et al. 2011). 
After H2AX phosphorylation, the ATM kinase, which is retained at the damage site, 
promotes -H2AX signal amplification and propagation up to several Mb on each side 
of the DSBs in mammals (Emmy P. Rogakou et al. 1999).  
Therefore, once phosphorylated, H2AX is able to trigger chromatin structural 
alterations at the DNA damage site to promote DNA repair. Overall, it seems to have 
both structural and functional roles cooperating in chromatin decondensation and 
retention of specific factors close to the DSB (Kruhlak et al. 2006; Celeste et al. 2003).  
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An alternative and intriguing DSB repair mechanism has been recently described in 
the work of Onozawa and colleagues. Both induced and spontaneous DNA DSBs were 
demonstrated to be repaired by the insertion of 50 to 1000 bp sequences termed 
“template-sequence insertions” (TSIs) derived from distant regions of the genome 
(Onozawa et al. 2014) . These TSIs were derived from genic, retrotransposon, or 
telomere sequences and were not deleted from the donor site in the genome, leading to 
the hypothesis that they were derived from reverse-transcribed RNA. 
1.4.5 Investigating -H2AX and DSBs in physiological conditions  
So far, the majority of the experimental efforts have focused on studying exogenous 
DSBs in different cellular systems after ionizing radiation (IR) exposure or after 
treatment with chemical compounds able to artificially induce DSBs. 
Although DSBs are mostly stochastic and pathological in nature, they can also be 
intermediates of physiological processes such as antigen receptor diversification in 
lymphocytes (Cui and Meek 2007), retrotransposition (Gasior et al. 2006) and 
transcription (Seo et al. 2012a; Madabhushi et al. 2015). 
Frequency of endogenous DSBs  
Replicating cancerous cells are characterized by high levels of naturally occurring 
DSBs (Seo et al. 2012a) but little is known about the frequency of DSBs occurring in 
healthy cells or tissues under physiological conditions.  
Are endogenous DSBs too rare to be biologically relevant in normal cells? 
One answer came from a work published in 2003 from Vilenchik and Knudson in 
which they demonstrated that endogenous DSBs produced at sites of single strand 
lesions (SSLs) during cell S-phase have a rate of 50 events per cell cycle in mammalian 
cells. Moreover, the rate of DSBs production was estimated to be approximately equal 
to that produced by 1.5 Gy of IR (Vilenchik and Knudson 2003). 
Interestingly, DSBs frequency can vary among cell types differing in specific 
exposure and response to endogenous free radicals, environmental stresses and in 
genomic replication rates (Hedges and Deininger 2007). 
Endogenous DSBs distribution in the genome 
Important information about genome distribution of endogenous DSBs was obtained 
with the development of the DSB-Capture technique. DSB-Capture is a sequencing-
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based method able to detect DSBs in situ and directly map these at single-nucleotide 
resolution (Lensing et al. 2016). Endogenous DSBs profiling was generated for normal 
human epidermal keratynocytes (NHEK), providing the most comprehensive DSB 
landscape in a normal human cell line.  
Lensing and colleagues showed that the vast majority (76%) of DSBs overlap with 
DNAseI sensible sites, suggesting a link between regulatory chromatin and genome 
instability. Moreover, DSBs also correlated with markers of active genes, enhancer 
regions, CTCF binding sites and the transcription start factor p63. Interestingly, 38% of 
DSBs overlapped with RNA PolII sites linking DSBs to transcription. Overall genic 
regions, particularly 5’ UTRs and promoters, were enriched compared to intergenic 
ones. Finally, increased gene expression was correlated with increased DNA damage 
around TSS, whereas damage within gene bodies showed little association with gene 
expression. Finally, no enrichment was found in heterochromatic regions (Lensing et 
al., 2016).  
Interestingly an earlier work investigating endogenous DSBs distribution with a 
completely different approach (chromatin immunoprecipitation and sequencing 
experiment (Chip-seq) for -H2AX) obtained concordant results (Seo et al., 2012). 
Chip-seq data from human replicating cells (Jurkat cells) demonstrated -H2AX 
preferential distribution in euchromatic portions of the genome in particular at the active 
TSSs (Seo et al., 2012). 
1.4.6 Sources of naturally occurring DSBs 
Endogenous DSBs can arise spontaneously during DNA replication as a result of 
oncogenic stress. Naturally-occurring DSBs as intermediates of LINE-1 
retrotransposition have been extensively described in the previous paragraphs. 
Nevertheless, other physiological processes can be correlated with the formation of 
endogenous DSBs. Here we report some examples: 
DSBs in VDJ recombination 
A well characterized role for naturally occurring DSBs comes from the immune 
system, where RAG1/RAG2-induced DNA-DSBs are key mediators of V(D)J 
recombination, (Cui and Meek, 2007). Moreover, it has been demonstrated that -
H2AX, which is highly phosphorylated in response to V(D)J recombination, has a role 
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in coordinating DSB repair with cellular proliferation and survival to prevent 
translocations and suppress lymphomagenesis (Yin and Bassing 2008). 
Controversial role of DSBs in transcription 
Transcription can be a source of genomic instability due to possible interference with 
the DNA replication machinery, causing replication fork stalling eventually associated 
with DNA damage and recombination (Fong, Cattoglio, and Tjian 2013) (Branzei and 
Foiani 2010) (Aguilera 2002). Moreover, it has been reported that DSBs occurring 
within a gene body inhibit the transcription of the gene, while the transcription of 
adjacent genes is not altered (Pankotai et al. 2012). 
Other works reported that actively transcribed genes are usually hotspots for DNA 
DSBs but at the same time they are repaired faster than non-transcribed genes. This 
suggests a role for transcription in the repair of DSBs (Chaurasia et al. 2012). 
Possible involvement of endogenous DSBs in transcription has been described in two 
recent works showing that DNA DSBs is coupled and necessary  for transcriptional 
activation and elongation of stimulus inducible genes in mice and human (Madabhushi 
et al., 2015) (Bunch et al. 2015). 
In particular, Madabhushi and colleagues, using both molecular and genome-wide 
next-generation sequencing methods, demonstrated that neuronal activity NMDA 
stimulation causes the formation of DSBs in the promoters of a subset of early-response 
genes in mouse primary cortical neurons (Madabhushi et al., 2015). Surprisingly, the 
specific chemical induction of DSBs within the promoter of selected early response 
genes induces their expression even in absence of an external stimulus (Madabhushi et 
al., 2015). Moreover, activity-dependent DSB formation is mediated by type II 
topoisomerase (Topo II) (Madabhushi et al., 2015). Overall DSB formation is shown to 
be a physiological event that rapidly resolves topological constraints to early-response 
gene expression in neurons (Madabhushi et al., 2015). In the same year, the group of 
Calderwood demonstrated that -H2AX is accumulated during RNA Pol II pausing 
release in TSSs of stimulus-inducible protein coding genes in humans (Bunch et al., 
2015). 
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DSBs as mediator of DNA topological stress 
Additional data suggesting possible roles of DSBs in physiological conditions come 
from different works published in 2013 by the groups of Kravatsky and Kretova that 
developed a method for precise genome-wide mapping of DSBs in human 
chromosomes (Tchurikov et al., 2013). DSBs hotspots distribute preferentially within 
genomic regions characterized by H3K27ac and H3K4me3 marks and CTCF binding 
sites (Tchurikov et al. 2013). Moreover, DSBs hot spots are scattered along 
chromosomes and delimit 50–250 kb DNA domains. Interestingly, 30% of the domains 
possess coordinately expressed genes, therefore DSBs distributed outside both silenced 
and expressed gene clusters together with the insulator protein CTCF. These results are 
consistent with the view that DSBs are involved in reducing topological stress imposed 
by long regions of uniform chromatin states (Tchurikov et al., 2013).   
Supporting observations come from an analysis of CTCF in mammalian cells, 
showing that CTCF can orchestrate long-range chromosomal interactions, suggesting a 
mechanism by which insulators establish regulatory domains (Kurukuti et al. 2006).  
Reimand and colleagues demonstrated that type II Topoisomerase  bound CTCF 
binding sites flanking transcriptionally associated domains (TADs) where are involved 
in solving topological constrains (Uusküla-Reimand et al. 2016). 
Moreover, a ChIP-seq analysis of CTCF-binding sites distribution in the genome of 
primary human fibroblasts demonstrated that the majority of CTCF signal was depleted 
within gene clusters (Kim et al. 2007).  
Finally, two recent works demonstrated that CTCF orientation is important for 
regulation of HOX (Narendra et al. 2015) and  protocadherin clusters (Guo et al. 2015). 
-H2AX involvement in additional biological processes 
Recently, increasing experimental evidence supported the involvement of DSB-
induced -H2AX in several non-canonical physiological processes besides DNA-
damage response. X-chromosome inactivation in somatic cells, neural stem cell 
development and cellular senescence maintenance are some of the numerous biological 
processes in which -H2AX can perform both functional and structural roles. A detailed 
description of -H2AX involvement in all the cited biological process is present in 
(Turinetto and Giachino 2015). 
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Non-canonical biological roles for -H2AX open the possibility that it can be 
involved in specialized functions in different cell types. Possibly, for all the -H2AX 
supported-biological processes, the occurrence of both induced and endogenous DSBs 
promotes the initial H2AX phosphorylation. Once phosphorylated, H2AX becomes 
central to several biological functions possibly unrelated to the DNA DSB response in 
strict sense (Turinetto and Giachino, 2015). 
1.4.7 Investigation of endogenous -H2AX in mouse tissues 
The first evidence of endogenous -H2AX expression in mouse tissues comes from 
the work of Sedelnikova and colleagues in which five mouse organs (liver, testis, 
kidney, lung and brain) were shown to display H2AX phosphorylation (Sedelnikova et 
al. 2004). A further exhaustive analysis of endogenous -H2AX distribution in mouse 
brain revealed that γ-H2AX is expressed from embryonic life to senescence in the 
absence of experimentally evoked damage to cellular DNA. In particular, neurogenic 
areas of the forebrain and cerebellum showed both focal and non-focal phosphorylation 
of H2AX that was shown to be linked to cell proliferation. On the other hand, in 
cerebral cortex of senescent mice γ-H2AX foci are most likely related to DSB 
occurrence and repair (Barral et al. 2014). 
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1.5 Objective 
 With this work we aim to assess whether genome instability could be involved in 
olfaction.  
The overall objective of the project consists in understanding the possible role of 
somatic genomic variations associated to LINE-1 in the regulation of OR choice in the 
mouse OE. To achieve this final goal, we organized the research work around four 
intermediate objectives: 
 
 Investigation of LINE-1 expression and mobilization in mouse OE (3.1) 
 
 Identification of LINE-1 associated structural variations in Olfr2 locus (3.2) 
 
 Validation of identified deletions (3.3) 
 
 Genome-wide analysis of endogenous H2AX in mouse OE and Liver (L) (3.4)
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2 Methods and Materials 
 
2.1 Animals 
C57BL/6J (Harlan) mice were obtained from SISSA animal facility; 
B6;129P2Olfr2 tm1Mom/MomJ  (Jackson) were kindly provided by the professor Anna 
Menini (SISSA). All animal experiments were performed in accordance with European 
guidelines for animal care and following SISSA Ethical Committee permissions. Mice 
were housed and bred in SISSA non-SPF animal facility, with 12 hour dark/light cycles 
and controlled temperature and humidity. Mice had ad libitum access to food and water. 
2.1.1 B6;129P2Olfr2tm1Mom/MomJ 
B6;129P2Olfr2
tm1Mom
/MomJ are characterized by OSNs expressing the mutated locus 
co-express tauGFP by virtue of internal ribosomal entry site (IRES)-mediated co-
translation (Bozza et al. 2002). Olfr2/GFP-expressing OSNs are visible under 
fluorescent microscope due to GFP auto-fluorescence. 
2.1.2 Summary of all mouse samples for each experiment 
 
Table 2.1. Summary of all mouse samples. For each experiment performed in this thesis, mouse strain, 
tissues and ages are indicated. OE, olfactory epithelium; K, kidney; Cer, cerebellum; L, liver; H, 
hippocampus. 1m/3m/12m, one /three/twelve months after birth; p6/p21, six days/twentyone days after 
birth. 
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2.2 Genomic DNA extraction 
Mouse tissues were dissected from C57BL/6J. Tissues were homogenized at room 
temperature in 1ml of lysis buffer (Tris pH 8.0 100mM; EDTA pH 8.0 5mM; SDS 
0.5%; NaCl 150mM) using a glass-Teflon potter. RNA was digested by incubation at 
37°C for 1 hour with Rnase A (40 μg/mL) (Sigma). After having added the Proteinase 
K (Roche) with a final concentration of 10 μg/mL, samples were incubated O/N at 
37°C. The day after, genomic DNA was extracted using the phenol/chloroform/isoamyl 
alcohol method: 1 volume of phenol (water-saturated, pH 8.0) (Sigma) was added to the 
samples, followed by a centrifugation at 10000 rpm for 20 minutes. The aqueous upper 
phase was collected in a new tube, and 1 volume of phenol:(chloroform-isoamyl alcohol 
(24:1)) was added, followed by a centrifugation at 10000 rpm for 10 minutes. The upper 
aqueous phase was again collected in a new tube, 1 volume of chloroform:isoamyl 
alcohol (24:1) was added and centrifuged at 10000 rpm for 10 minutes. The resulting 
upper aqueous phase was finally collected in a new tube and DNA was precipitated by 
adding two volumes of 100% ethanol. DNA white flakes were transferred into fresh 
tubes containing 200 μL of 70% ethanol and centrifuged at 12000 rpm for 15 minutes at 
4°C in order to wash and gradually hydrate them. After ethanol removal, the DNA 
pellets were air dried and dissolved in 300 μL of Tris 10mM pH 8.0 O/N. The DNA 
quality was finally assessed by gel electrophoresis using a 0.9% ethidium bromide 
agarose gel.  
2.2.1 Genomic DNA quantification using Quant-iTTM PicoGreen® 
dsDNA kit (Invitrogen) 
The copy number variation analysis performed in this study needs to detect very 
small differences in a high number of copies of the target DNA (LINE-1) between 
different samples. For this reason, it is necessary to use a precisely quantified small 
amount of genomic DNA. According to the literature (Coufal et al., 2009), the proper 
amount of genomic DNA for this analysis is 80 picograms corresponding approximately 
to 12 genomes. Therefore, the Quant-iTTM PicoGreen® dsDNA kit (Invitrogen) was 
used as a highly sensitive DNA quantification system. Quant-iTTM PicoGreen® 
dsDNA kit (Invitrogen) is an ultrasensitive double strand DNA (dsDNA) quantification 
method which allows to detect and quantify extremely small amounts of DNA in 
solution, from 25 pg/mL up to 1000 ng/mL. In this study, DNA concentrations raging 
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from 0,9 ng/mL and 1,1 ng/mL were accepted. Quantification of gDNA for LINE-1 
CNV assay was performed by Lavinia Floreani.  
2.3 Total RNA extraction 
Mouse tissues were dissected from C57BL/6J mice at the age of p21 and 
immediately snap frozen in liquid nitrogen. Total RNA was extracted using Trizol 
(Invitrogen) according to manufacture’s instructions. RNA samples were treated with 
DNase I (Ambion). cDNA was prepared from 1 μg of RNA using the iSCRIPT™ 
cDNA Synthesis Kit (Bio-Rad) according to manufacturer’s instructions. 
2.4 Quantitative Real-Time PCR (RT-qPCR) with Taqman 
probes. 
In this work, a Taqman multiplex RT-qPCR with relative quantification was 
performed. Quantitative PCR experiments were performed using iQ5 real-time PCR 
detection system (BIORAD). For each sample, calibration curves of cDNA or genomic 
DNA were assayed to verify both amplification efficiencies and whether the dilution 
point chosen for the analysis was within the linear range of the reaction. Data obtained 
by qPCR co-amplifications of the target DNA sequence (LINE-1) and the internal 
invariable control were analyzed using the 2
–ΔΔCt
 
(Livak and Schmittgen, 2001) 
method. Standardization was performed considering the highest ΔCt value as 
calibrator. Statistical analysis of the data obtained by a minimum of three qPCR replica 
was performed by the paired, two-tailed, Student’s t-test. Values were considered 
statistically significant when p-value resulted < 0.05.  
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2.4.1 LINE-1 expression and copy number variation (CNV) Taqman 
assays 
 
Figure 2.1. Multiplex quantitative PCR assay for mouse LINE1 (L1) expression and copy number 
variation analysis. A cartoon of the rationale of the multiplex qPCR used in this study is shown. After 
retrotransposition most of LINE-1 elements are 5’ truncated and inactive. Taking advantage of this 
peculiarity, specific Taqman probes were designed to discriminate intact full length L1 (5’UTR probe, 
yellow box) from retrotransposed copies, which are 5’ truncated (ORF2 probe, blue box). 
Previously in our lab a new assay to assess LINE-1 retrotransposition in mouse 
tissues was developed, based on the protocol published by Coufal and colleagues in 
humans (Coufal et al., 2009). This technique uses Taqman RT-qPCR to evaluate LINE-
1 copy number but can be suitable also for evaluate LINE-1 mRNA expression. Taqman 
qPCR strategy was planned considering that LINE-1 5’ UTR probes detect LINE-1 full 
length forms, corresponding to original LINE-1 elements. Probes complementary to the 
ORF2 region at the LINE-1 3’end detect the entire LINE-1 repertoire, including both 
full length and truncated forms, which correspond to both original and retrotransposed 
LINE-1 elements. Since murine 5’UTR region of LINE-1 is composed of different 
repetitive monomers which characterize different LINE-1 subfamilies, we designed 
specific probes for each active mouse LINE-1 type (A, Tf and Gf) (Figure 2.1) (Goodier 
et al., 2001). In this way, we were able to discriminate between the different mouse L1 
subfamilies. In order to perform a relative quantification of the truncated and the full 
length LINE1 copies, we used, as internal controls, Taqman probes designed against 
glycerhaldeyde 3-phosphate dehydrogenase or GAPDH for expression assay, and 
MicSAT for CNV assay (Table 2.2). RT-qPCR cyclying conditions are shown in Table 
2.3. 
RT-qPCR assay for LINE-1 CNV was performed by Lavinia Floreani. 
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Table 2.2. List of primer used for RT-qPCR Taqman assays. 
 
Table 2.3. RT-qPCR cycling conditions 
 
2.5 Western Blot 
Total protein lysates from mouse tissues were prepared by homogenization in 
Sample Buffer 2× (4% SDS, 20% Glycerol, 0.12M Tris pH 6.8, and 10% BME). Equal 
amount of proteins was separated in 15% SDS-polyacrylamide gel transferred to 
nitrocellulose membrane. Immunoblotting was performed with the following primary 
antibodies: Anti-phospho-Histone H2A.X 1:1000 (Ser139) (clone JBW301, Millipore), 
anti-Histone H2A.X 1:1000 (ab11175, Abcam), anti-βactin 1:10000 (A5441, Sigma). 
All primary antibodies were incubated overnight at 4°C. 
Signals were revealed by using ECL (Amersham) after one-hour incubation at room 
temperature with secondary antibodies conjugated with horseradish peroxidase. 
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2.6 Immunohistochemistry 
C57BL/6J mice were sacrificed by decapitation and cervical dislocation.  
L, K and Cer were dissected from C57BL/6J mice at p6 and left overnight at 4°C in 4% 
paraformaldehyde (PFA). For OE, after mouse decapitation, the skin and the jaw were 
removed from the heads. In parallel the entire liver was dissected, then the samples 
were left overnight at 4°C in 4% paraformaldehyde (PFA). Only for 1 month old mice, 
the head was incubated overnight in EDTA solution 0.5M pH 8 for an additional 
decalcification step. All tissues, after a 4-h cryoprotection step in a 30% sucrose/1× 
PBS solution at 4°C, were included in Frozen section medium Neg-50 (Richard Allan 
Scientific) and snap frozen in liquid nitrogen. Frozen blocks were brought into a 
cryostat (Microm International) and left for 60 min at −21°C, if not used, they were 
stored at -80°C.  
Immunohistochemistry was performed 16 μm-thick cryo-slices prepared with 
Vibratome 1000s (Leica), both prepared from 6 days (p6) and 1 month old C57BL/6J 
mice (n = 3). Slides were blocked with PBS, 10% FBS, 1% BSA, and 1% fish gelatine 
(filtered) for 1 h at room temperature, and the primary (anti-Line1 1:100 M300, Santa 
Cruz, anti-Olfactory Marker Protein 1:2000 544-10001, Wako) and secondary 
antibodies were diluted in PBS, 1% BSA, 0.1% fish gelatine, and 0.3% Triton X-100. 
Incubation with primary antibodies was performed for 16 h at room temperature; 
Incubation with conjugated-secondary antibodies was performed for 2 h at room 
temperature. Nuclei were labelled with DAPI. Slides were mounted with mounting 
medium for fluorescence Vectashield (Vector Lab) and observed with a confocal 
microscope.  
2.7 Methods for gene clusters identification, random regions 
selection, repeats annotation and coverage calculation 
Data collection – mouse genome (assembly GRCm38) was downloaded from 
Ensembl (release 85)1 FTP (ftp://ftp.ensembl.org/pub/release-
85/fasta/mus_musculus/dna/Mus_musculus.GRCm38.dna.primary_assembly.fa.gz). 
Pfam2 gene domain annotations were downloaded from BioMart. 
Identification of gene clusters – gene clusters table was generated based on 
physical gene location using python scripts. In particular, two consecutive genes sharing 
the same domain were considered to belong to a cluster if the distance between them is 
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≤ 500 Kbp regardless of the presence of other genes within the cluster, a threshold 
already used in other gene family studies. 
Random regions selection – random regions were selected relying on gene cluster 
composition in order to reflect their length. Each gene cluster was randomized 100 
times using the shuffleBed program from BEDTools5 denying shuffled intervals to 
overlap each other and to fall inside gene cluster intervals with the next parameters: -
noOverlapping, -excl. 
Repeats annotation – repetitive elements were annotated using RepeatMasker 
(v4.0.6) against Repbase database (v20.05 – Release 20150807) with the next 
parameters: -species mouse, -s, -gff. 
 
Coverage calculation – a simple python script was used to divide repetitive 
elements in families and the coverage was calculated for each kind of gene cluster and 
its respective randomizations using coverageBed from BEDTools with default 
parameters. Finally, the mean and the standard deviation were obtained from the 
hundred randomization ad plotted together with the cluster coverage in the final barplot 
using R (v3.3.1) and ggplot2 (2.1.0). 
Analysis was performed by Massimiliano Volpe. 
2.8 Sample preparation for Laser Capture Microdissector 
OE samples were prepared from 6 days old B6;129P2-Olfr2
tm1Mom
/MomJ (Olfr2-
GFP mice). After decapitation, the skin and the jaw were removed from the heads, and 
the samples were left overnight in 1× ZincFix fixative (BD Biosciences) diluted in 
DEPC-treated water. After a 4-h cryoprotection step in a 30% sucrose/1× ZincFix 
solution, heads were included in Frozen section medium Neg-50 (Richard Allan 
Scientific) and snap frozen in liquid nitrogen. Frozen blocks were brought into a 
cryostat (Microm International) and left for 60 min at −21°C. Serial coronal sections of 
mouse heads (14 μm) were cut with a clean blade, transferred on PEN-coated P.A.L.M. 
MembraneSlides (P.A.L.M. Microlaser Technologies), and immediately stored at 
−80°C. Before usage, the slides were brought to room temperature and air-dried for 2 
min. The MOE was morphologically identified and different pools of GFP-positive and 
GFP negative OSNs were selected with fluorescent microscope, microdissected, and 
collected with a Zeiss P.A.L.M. LCM microscope (Carl Zeiss Inc.) in P.A.L.M. tubes 
Methods and Materials 
 
 45 
with adhesive caps and immediately used for subsequent whole genome amplification 
(Figure 2.2). 
 
Figure 2.2. Laser capture microdissection, capitulation and collection of GFP-positive cells from 
OE. 
 
2.9 Whole genome amplification (WGA) 
2.9.1 Multiple Displacement Amplification (MDA) 
Multiple displacement amplification is a non-PCR based DNA amplification 
technique. This method can rapidly amplify minute amounts of DNA samples to a 
reasonable quantity for genomic analysis. The reaction starts by annealing random 
hexamer primers to the template: DNA synthesis is carried out by a high fidelity 
enzyme, called 29 DNA polymerase, at a constant temperature. In this work we used 
Repli-g Single Cell kit (QIAGEN), a commercially available MDA kit specialized for 
single cells starting material. We followed the manufacture’s instructions and we 
incubated the samples for amplification 16 hours at 30°C. After amplification, MDA 
products were checked on 0.8% agarose gel before and after column purification with 
QIAquick PCR purification kit. Compared with conventional PCR amplification 
techniques, MDA generates larger sized products (5-10 kb) without PCR amplification 
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biases: for this reason, we chose MDA amplification as definitive method to produce 
starting DNA material to use in downstream analysis. Nevertheless, we were aware of 
possible MDA amplification artifacts, in fact we included a non-MDA control sample 
(OE sample) in the experiment.  
2.10 Long Range PCR (LR-PCR) amplification of 50 kb Olfr2 
locus  
Purified MDA products and bulk genomic DNA (without any MDA amplification) 
were used as template for LR-PCR amplification of 50 kb genomic sequence around 
Olfr2 TSS. For a first Pac Bio sequencing the 50 kb around Olfr2 gene were divided 
into 11 amplicons of about 5 kb each. For the subsequent Illumina sequencing the 50 kb 
sequence locus was divided into 13 amplicons with a size ranging from about 400 bp to 
about 5 kb (amplicon 2 was divided into three sub-amplicons for Illumina sequencing). 
We performed the PCR amplification using a LR-PCR amplification kit (QIAGEN) 
following the manufacture’s instruction. For each PCR reaction we used about 100 ng 
of purified MDA product or bulk genomic DNA. PCR products were check on 0.9% 
agarose gel and purified with QIAquick PCR purification kit (QIAGEN) following the 
manufacture’s. Purified products were quantified with Nano Drop (ThermoScientific). 
LR-PCR program and primer used are shown in Table 2.4. and Table 2.5, 
respectively. 
 
Table 2.4. Long Range PCR reaction cycling conditions. Denaturation, annealing and extension steps 
were repeated for 35 cycles. 
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Table 2.5. List of primers used for Long Range PCR amplification of 50kb Olfr2 locus. Primers were 
designed on the reverse strand. 
 
2.11 Sequencing techniques 
2.11.1 Pac Bio RS II sequencing 
Sequencing was performed at GATC Biotech (Germany). Pac Bio RS II is a single 
molecule real time sequencing technique based on the properties of zero-mode 
waveguides, developed by Pacific Biosciences of California, Inc. This technique is 
characterized by the ability to sequence very long reads with high accuracy and 
coverage without any PCR amplification bias. For these reasons it is particularly 
suitable for the detection of structural variations. 
LR-PCR products of each amplicon were pooled together in equimolar ratio to reach 
2g of total DNA and sent for sequencing. A total of two Pac Bio libraries were 
sequenced. 
2.11.2 MiSeq Illumina Sequencing 
Sequencing was performed at IGA Technology Services (Udine). MiSeq sequencing 
technology can produce 2 x 300 paired-end reads in a single run, allowing detection of 
target variants with unmatched accuracy, especially within homopolymer regions. 
Illumina sequencing DNA-libraries were built for each of DNA amplicons for the three 
samples, a total of 39 libraries were sequenced. 
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2.11.3 Bioinformatic analysis and structural variation discovery 
Pac Bio and Illumina reads were mapped with BWA MEM (http://bio-
bwa.sourceforge.net/) on reference mouse genome (GCRm38/mm10 assembly).  
Variation discovery on Illumina reads was performed with Pindel bioinformatics 
tool. 
Here we report some Pindel parameters which have to be taken into account for the 
interpretation of the results.  
1) Threshold coverage: minimum coverage of 5 Illumina reads was chosen, meaning 
that each variation has to be covered by at least 5 reads in at least one sample to be 
included in Pindel output. Therefore, when a variation is associated to a specific sample 
(with at least 5 supporting reads), it could be present also in the other samples with a 
coverage under the 5 reads threshold.  
2) Length range: we considered only variations longer than 50 bp and shorter than 
the length of the correspondent PCR amplicon. An exception was done for insertions 
since Pindel algorithm can identify only very short insertions (500 bp as maximum). 
3) Variation identity: Pindel recognizes two variations as different if their 
coordinates diverged for at least 1 bp.  
Bionformatics analyses were performed by Aurora Maurizio. 
 
2.12 Deletions repeat enrichment 
Repeat description in correspondence of the deletions was based on repeatmasker 
annotation (rmsk) (http://www.repeatmasker.org/). Bedtools intersect were used 
(Quinlan and Hall 2010).  
Analyses were performed by Aurora Maurizio 
2.13 Pac Bio validation 
High-identity Illumina sequencing dataset was combined with a complementary Pac 
Bio data set. Pac Bio long reads reads were employed to validate Pindel deletions. 
Illumina split reads supporting the deletions were aligned over PB reads using blastn, 
regardless the sample (NB: reads supporting the deletions found in the OE sample were 
aligned also over Pac Bio reads coming from the MDA sample and viceversa). 
blastn parameters (word_size 20, perc_identity 85, evalue 1e-10) (Altschul et al. 1990). 
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85 % minimum identity was imposed because of the 14% error rate affecting PacBio 
reads. 
Each query Illumina fasta sequence should align for its entire length (+- 10 bp) over 
the corresponding Pac Bio read in order to consider the deletion supported by the 
Illumina read validated.  
Bionformatics analyses were performed by Aurora Maurizio 
2.14 End-point PCR validation assay 
Validation PCR assays were performed with ExTaq DNA-Polymerase (Takara) 
following the manufacture’s protocol.  
 
Table 2.6. Validation PCR reaction cycling conditions. Denaturation, annealing and extension steps 
were repeated for 40 cycles. 
When necessary, we adapted melting temperatures and DNA polymerase extension 
step depending on the specific primers features for each validation assay. A list of 
validation primers used is shown in Table 2.7. 
 
 
Table 2.7. List of primers used for Pindel deletion validation PCR assays. Primers were designed on 
the forward strand. 
 
Sanger sequences were analyzed with UCSC Blat tool and with NCBI Blast tool in 
order to verify whether they were supporting any Pindel deletion.  
Representation of Sanger sequences, Illumina reads and Pindel deletions are shown 
in the results as screenshots of uploaded tracks on USCS Genome Browser tool.  
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2.15 Chromatin Immunoprecipitation (ChIP) 
Mouse tissues were lysed and cross-linked in freshly prepared 1% formaldehyde 
solution.  The crosslinking reaction was stopped by adding Glycine (0.125 M), then the 
tissue was homogenized using a Dounce homogenizer and sonicated.  
100 g of chromatin sample was immuno-precipitated O/N with 2 ug of anti-
phospho-Histone H2A.X (Ser139) Antibody (clone JBW301, Millipore) or with IgG-
conjugated magnetic beads. DNA was de-crosslinked at 65°C O/N and extracted with 
standard phenol/clorophorm protocol (see genomic DNA extraction). Finally, extracted 
DNA was quantified with Picogreen. For each sample 10 ng of IP DNA and input DNA 
were sent for Illumina sequencing libraries construction. 
2.15.1 ChIP samples sequencing and bioinformatics analysis 
ChIP samples were sequenced with Illumina High Seq paired-end sequencing at 
Deep Seq facility of School of Life Sciences, Queen's Medical Centre at Nottingham 
University.  
A filtering pipeline was used to filter reads with low sequencing score and reads 
aligning to adaptor sequences. First, raw reads were trimmed against adaptors using 
scythe (https://github.com/vsbuffalo/scythe). The remaining reads were quality trimmed 
using sickle (https://github.com/najoshi/sickle). Reads passing the filters were mapped 
to the mouse reference genome (build mm10/GRCm38) using bwa (http://bio-
bwa.sourceforge.net/). In the bam files obtained, duplicates were marked using picard 
and filtering was performed in order to remove reads with mapping quality below 60, 
duplicates and improper pairs. The filtered data was further sorted and mate fixed. 
Filtering, sorting and mate fixing were performed using samtools (version 0.1.19). Bam 
files were then converted to paired-end bed format using bamToBed utility from 
bedtools suite (version 2.25.0). Peak calling was performed on the filtered data using 
epic (version 0.1.18), a peak caller based on SICER suitable to identify diffused 
domains of enrichment, which is the pattern expected for gamma-H2AX signal. 
A simple perl script was used to convert epic outputs to bed format (conversion 
includes: ordering the columns as appropriate for bed format, substitute spaces with 
tabs, assign an ID to each peak, defined as chromosome_start). From each of the 
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resulting bed files peaks overlapping blacklisted genomic regions were removed using 
intersectBed from bedtools suite. Blacklisted regions for mm9 were downloaded from 
https://sites.google.com/site/anshulkundaje/projects/blacklists and lifted to mm10 using 
the UCSC Genome Browser liftOver tool (https://genome.ucsc.edu/cgi-bin/hgLiftOver). 
To obtain a representative set of ChIP-seq peaks for each biological condition (liver at 
P6, OE at P6 and OE at 1 month) we considered the intersection of the peak sets 
obtained in the two replicates and these were used in subsequent analyses.  
The bioinformatics methods described above were performed by Margherita 
Francescatto. 
 
Peak genomic distribution 
Peak annotation was performed with ChIP-seq NEBULA online-tool specific for 
ChIP experiments on histone modifications (Boeva et al. 2012). Default parameters 
were used for the analysis. 
 
Gene Ontology (GO) functional annotation 
GO enrichment analysis was performed using GREAT online tool. For each peak the 
nearest TSS was annotated within 1 Mb. Each sample dataset (foreground dataset) was 
analyzed using all the other sample datasets as background dataset. Only GO terms with 
FDR<0.01 were included in the output (McLean et al. 2010). 
 
Peak annotation with respect to mouse CpG islands 
The annotation of the peaks identified with respect to CpG islands was performed 
using the AnnotatePeak.pl function of the HOMER suite of tools (Heinz et al. 2010). 
Analyses performed by Margherita Francescatto. 
 
Peak annotation with respect to different class of repeats 
Analyses were performed by Massimiliano Volpe. 
 
Comparison of ChIP-seq peaks with L and OE expression data 
Liver CAGE expression data 
Liver expression data was derived from the mouse tissue catalogue of FANTOM5 
consortium. The table containing normalized expression values across all mouse 
samples profiled within phases I and II of the FANTOM5 project (Arner et al. 2015) 
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was downloaded from FANTOM5 website 
(http://fantom.gsc.riken.jp/5/datafiles/latest/extra/CAGE_peaks/mm9.cage_peak_phase
1and2combined_tpm_ann.osc.txt.gz). The data corresponding to liver neonatal samples 
closer to the age of mice for which we have ChIP-seq data (N6, N7, N10, N20, N25 and 
N30) was extracted using a custom R script. Data was filtered in order to retain only 
CAGE peaks with at least 1tpm (tpm=tags per million) in all samples. A file in bed 
format was created reporting genomic coordinates of CAGE peaks, peak annotation and 
average expression. Since FANTOM5 expression data is natively annotated in mm9, we 
lifted the bed file to mm10 using the liftOver tool (https://genome.ucsc.edu/cgi-
bin/hgLiftOver). 
OE expression data 
Expression data from the work of Ibarra-Soria and colleaues (Ibarra-Soria et al. 
2014) was downloaded, converted to tab separated format and used to create a bed file 
containing TSS coordinates (transcription start site +40 bp to make it generally 
comparable to CAGE peaks), corresponding annotation and average expression across 
the 6 replicates. 
Expression correlation analyses were performed by Margherita Francescatto. 
 
Comparison with chromatin segmentation of the L mouse genome 
We downloaded 11 ChIP-seq datasets in bigWig format: 
- 7 liver histone marks (H3k27ac, H3k27me3, H3k36me3, H3k4me1, H3k4me3, 
H3k79me2, H3k9ac) and corresponding input were downloaded from 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31039 
- liver CTCF and Pol2 ChIP-seq and corresponding input were downloaded from 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29184 
All bigWig files were converted to bedgraph using the bigWigToBedGraph tool 
(downloaded from UCSC genome browser, 
hgdownload.cse.ucsc.edu/admin/exe/linux.x86_64/bigWigToBedGraph). The data was 
then binned using the chromhmm-tools (https://github.com/daler/chromhmm-
tools/blob/master/chromhmm_signalize.py). The file config.txt was created following 
instructions from chromhmm-tools manual. 
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The signal was then binarized using ChromHMM (Ernst and Kellis 2012)function 
"BinarizeSignal" and the HMM chromatin state model was built using the function 
"LearnModel", specifying 10 states and the genome build of interest (mm9). 
The relative enrichment of the states belonging to the segmentation so created with 
respect to the -H2AX peaks identified in the three conditions was calculated using the 
function "OverlapEnrichment". To identify peaks corresponding to enhancer regions as 
characterized by ChromHMM model we intersected (intersectBed) each of the three 
peak sets with the bed file containing the 10-state segmentation of the genome and 
extracted peaks overlapping state 3. 
Comparison with CTCF, Pol II and DNase data. 
Because the peak calling is not an exact process, we accepted two features to overlap 
if they were located with 1kb of each other (in other words, intersections were 
performed using windowBed from bedTool suite with w parameter set to 500). 
Intersection analyses were performed by Aurora Maurizio. 
Statistical analysis and plotting 
All statistical analysis and plots in sections X, Y, Z were performed using R. 
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3 Results  
3.1 LINE-1 expression and mobilization in mouse OE 
3.1.1 Validation of NanoCAGE data with qPCR Taqman assay 
We started our analysis validating recently published NanoCAGE data about LINE-1 
expression in mouse OE (Pascarella 2014), performing RT-qPCR with Taqman probes. 
Real time experiments were performed on C57BL/6J wild type mice at the age of p21, a 
total number of six mice were used. For each mouse we compared LINE-1 expression 
among three tissues: OE and cerebellum (Cer) as neuronal tissues and kidney (K) as 
non-neuronal one.  
Figure 3.1. RT-qPCR analysis for LINE-1 expression in mouse tissues in p21 wild type mice. 
Different RT-qPCR Taqman probes were designed for each of the three mouse LINE-1 subfamilies 
(A,Gf,Tf) and for the ORF2 coding sequence, common to all mouse LINE-1s. A probe on GAPDH was 
used as internal control. OE, olfactory epithelium; K, kidney; Cer, Cerebellum. A minimum of three 
independent replicates were performed for each assay. * p-values<0.05; **p-values < 0.01; *** p-values 
<0.001 derived from t-Student paired test. 
For all RT-qPCR assays (A, Tf, Gf and ORF2) we observed a higher expression of 
LINE-1 elements in OE compared with K and Cer. No significant differences were 
observed comparing Cer with K except for ORF2 assay, where LINE-1 expression in 
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cerebellum was significantly higher than in kidney (Figure 3.1). Overall these results 
confirmed the expression of both full length and 5’truncated LINE-1 transcripts in OE. 
3.1.2 LINE-1 ORF2 protein expression in mouse tissues 
To further confirm LINE-1 expression in OE we performed fluorescent-IHC 
experiments to compare LINE-1 ORF2 protein expression in different mouse tissues. 
We analyzed LINE-ORF2 protein signal in OE, Cer, K and liver (L) of C57BL/6J wild 
type mice at the age of p6. In agreement with RT-qPCR data we detected ORF2 protein 
signal mainly in OE and Cer compared with K, where no ORF2 signal was detected. 
Few positive cells were detected also in L.  
 
Figure 3.2. IHC anti LINE-1 ORF2 protein in C57BL/6J wild type mice. a. Merge signal (ORF2+ 
DAPI) were shown in 16 m frozen slices from each mouse tissue analyzed and for negative controls. 
OE, Olfactory epithelium; Cer, Cerebellum; K, kidney; L, liver. Nikon confocal 40x oil, zoom 4x. b. 
Anti-ORF2 signal in 16 mm frozen slices from 1m OE was shown in green, OMP signal was shown in 
red and DAPI in blue. Nikon confocal 40x oil, zoom 2x. For all the figures, Neg Cntrl = sample incubated 
only with secondary Ab. White bars correspond to 10 m. 
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Then, we looked in detail at OE. To verify whether ORF2 signal was localized only 
in mature OSNs, we performed a double fluorescent-IHC for ORF2 and for OMP, a 
cytoplasmic protein which labels only mature OSNs. We were able to observe a co-
localization of the two signals in the intermediate level of OE where mature OSNs are 
present. Interestingly ORF2 signal was diffused also in the basal layer of the epithelium 
were basal cells and OSN progenitors are located (Figure 3.2, b). 
Overall, ORF2 protein presented a punctuate expression pattern. It seemed to be 
localized preferentially in the cytoplasm but some positive nuclei were also observed in 
OE, Cer and L. 
3.1.3 LINE-1 CNV in mouse tissues  
We further investigated LINE-1 copy number variation (CNV) in different mouse 
tissues. We used the RT-qPCR CNV assay described in methods, able to detect both full 
length and truncated LINE-1elements. 
The CNV assay was performed in five C57BL/6J at 3 months of age for different 
neuronal and non-neuronal tissues: OE, hippocampus (H), K and liver (L). As 
previously observed (Coufal et al. 2009), we were able to detect a high number of 
LINE-1 sequences in H compared to K and L. Moreover, we surprisingly observed that 
LINE-1 mobilization was increased in OE compared with all other tissues (Figure 3.3). 
 
Figure 3.3. qPCR analysis of total LINE1 copy number in mouse tissues. Relative quantification of 
total LINE-1 obtained by qPCR using the ORF2-MICSAT Taqman probes. OE, olfactory epithelium; L, 
liver; K, kidney; H, Hippocampus. L1 ORF2 number is significantly higher in all brain regions respect to 
liver and kidneys. Each symbol represents the average of 3 qPCR independent replica. Red lines represent 
the average of all samples. Standard deviations are indicated. *P<0.05; **P<0.01; ***P<0.001 resulting 
from t-student paired test.  
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These results are consistent given the ability of OE, like the hippocampus, to 
constantly regenerate during the adult life on an organism thanks to the presence of 
neuronal stem cell populations (Hurtt et al., 1988). 
3.1.4 Analysis of repeats enrichment in OR clusters  
We then focused our attention on OR gene clusters, investigating the distribution of 
different classes of repeats within them (detailed method information in paragraph 2.7). 
Interestingly the OR-clusters showed a specific enrichment for LINE-1 elements 
compared with other classes of repeats. Surprisingly, LINE-1 enrichment was a 
peculiarity of OR genes. Indeed, other gene clusters analyzed presented enrichment in 
different classes of repeats (i.e: Zinc Finger clusters were enriched for LTRs) or no 
enrichment at all (i.e:Trypsin clusters) (Figure 3.4). 
 
 
Figure 3.4. Repeat enrichment analysis for different mouse gene clusters. Real clusters are shown in 
red and random clusters are shown in green. Black bars represent standard deviation for each repeat class 
enrichment.  
 
3.2 Structural variation (SV) discovery in Olfr2 locus 
Given the relatively high LINE-1 expression and increase in CNV in OE compared 
with other mouse tissues and given the peculiar LINE-1 enrichment in OR clusters, we 
decided to further investigate possible LINE-1 effects in a specific OR locus.  
We started to investigate whether LINE-1-associated non-annotated structural 
variations (LINE-1-SVs) are present in a selected OR locus. Moreover, to assess a link 
between LINE-1-SV and OR expression we performed the analysis in parallel on an 
active and an inactive locus of the same OR. 
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To this aim we took advantage of B6;129-Olfr2-GFP mice in which OSNs 
expressing Olfr2 receptor also express GFP protein. With this tool we were able to 
collect different pools of 10 GFP-positive cells expressing the receptor Olfr2 and 
carrying the active Olfr2 locus (see details in methods and material). In parallel bulk 
genomic DNA was extracted from total OE of an age-matched mouse from the same 
litter.  
We performed Olfr2 locus targeted-sequencing combining two different sequencing 
techniques, Pac Bio and Illumina systems. 
 
Experimental flowchart:  
 
3.2.1 Multiple displacement amplification (MDA) of 10 cells 
Different pools of 10 GFP-positive cells were collected by LCM from B6;129-Olfr2-
GFP mice at the age of p6 and immediately amplified with MDA, a whole genome 
amplification technique (see details 2.9.1). For all MDA replicas we obtained long DNA 
fragment output ranging from 1 to 10 kb (Figure 3.5). 
Random primer amplification in MDA negative control was expected from the MDA 
kit protocol (Figure 3.5). To verify successful Olfr2 locus amplification, we checked by 
PCR the presence of Olfr2 coding sequence (CDS) in each MDA amplified product 
(data shown in Appendix, Figure-A1. 
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Figure 3.5.Whole genome MDA amplification of 10 cells DNA. MDA amplification was performed on 
11 independent pools of 10 cells, previously collected by LCM. A positive control with 20 ng of gDNA 
as starting material and a negative control with no input material is shown. The presence of DNA in the 
MDA-negative control is expected due to random primer amplification. 
 
 
3.2.2 Long Range PCR (LR-PCR) amplification of the Olfr2 locus  
LR-PCR amplification of Olfr2 locus for Pac Bio sequencing 
 
Figure 3.6. Schematic representaion of 50 kb region around Olfr2 TSS locus. UCSC Genome 
Browser represetation of 50 kb on mouse chromosome 7 in Olfr2 locus. Black rectangles and red 
numbers indicated the PCR amplicons upstream (1-5) and downstream (6-11) the TSS (indicated with a 
black arrow). Red cyrcle indicates Olfr2 trascript. Olfr2 trascritpion is indicated on the reverse strand. 
In order to amplify 50 kb around Olfr2 transcription start site (TSS) (25 kb upstream 
and downstream the TSS) we divided the locus in 11 amplicons of about 5 kb each 
(Figure 3.6). We performed locus amplification on 11 MDA biological replicates (MDA 
I-XI), each derived from a pool of 10 GFP-positive cells collected by LCM. In parallel, 
we performed Olfr2 locus amplification from bulk genomic DNA, extracted from OE 
(gDNA-OE) and not amplified by MDA. Bulk OE DNA sample can be considered a 
“technical positive control” in order to be aware of possible MDA amplification 
artifacts formation which can compromise downstream PCR amplification. At the same 
time, it is a “negative biological control” because it consists of whole OE cell 
Results 
 
 60 
population among which Olfr2-expressing cells (GFP positive) represented less than the 
0.1% of all OSNs which are about ten million neurons. 
Therefore, we expected that if a putative genomic variation is involved in Olfr2 
expression it will be underrepresented or even undetectable in OE compared with MDA 
sample. 
The best PCR products from different MDA biological replicas and from bulk OE 
gDNA were purified ( all PCR reaction products ware purified) and pooled together for 
Pac Bio sequencing (Figure 3.7). 
 
 
Figure 3.7. LR-PCR amplification of 50 kb Olfr2 locus. Both panels show purified PCR products for 
11 amplicons covering 50 kb of Olfr2 locus in MDA sample (top panel) and OE sample (bottom panel), 
respectively. Each PCR was perform in parallel to negative control with no DNA input (data not shown).  
 
Pac Bio reads from MDA and OE samples were firstly mapped on the reference 
genome (MouseGRCm38/mm10 assembly) to verify the 50kb Olfr2 locus coverage 
with PCR amplification. For both the samples we were able to cover almost of the 
targeted locus, 82% and 72% of reads were mapped for MDA sample and gDNA-OE 
sample respectively, demonstrating that both MDA amplification and LR-PCR 
amplification techniques were successful. Unfortunately, LR-PCR amplification failed 
for amplicon 7, due to the presence of the long IRES-GFP construct, and for amplicon 2 
due to high density of repetitive sequences which made very difficult primer design. Pac 
Bio coverage is reported in Appendix (Figure-A 3). 
LR-PCR amplification of Olfr2 locus for Illumina sequencing 
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The same LR-PCR amplification of 50kb Olfr2 locus was performed for Illumina 
sequencing. Here we were able to optimize amplicon 2 PCR dividing it in three smaller 
sub-amplicons (called 2.1, 2.2 and 2.7). Therefore, for amplicon 2 we had only Illumina 
supporting reads. Amplicon 7 was excluded from the amplification due to the 
impossibility to cover by PCR IRES-GFP region. 
For Illumina sequencing we performed LR-PCR amplification of Olfr2 locus on two 
different MDA biological replicates out of 11 (MDA-V and MDA-XI) and on the same 
bulk OE gDNA (OE sample), used for Pac Bio. Finally, 13 PCR amplicons for each 
sample were sequenced for a total of 39 Illumina libraries. 
After sequencing, Illumina reads were mapped on the reference mouse genome 
(MouseGRCm38/mm10 assembly) to check for Olfr2 locus coverage among the three 
samples (MDA V, MDA XI and OE) (Figure 3.8). As for Pac Bio sequencing we 
obtained good coverage of the locus that was comparable between MDA and OE 
samples. Looking at the reads coverage comparing the 5’ and 3’ regions with respect to 
Olfr2 TSS, we observed that the most covered amplicons were located upstream the 
Olfr2 gene. 
 
Figure 3.8. Illumina sequencing coverage of 50kb Olfr2 locus. Coverage for OE (red), MDAV (light 
green) and MDA XI (dark green) sample is shown. Number of reads per Olfr2 50 kb locus coordinates 
are plotted. The arrow shows the amplification gap at the level of amplicon 7 due to IRES-GFP insertion. 
Minus strand is shown. 
3.2.3 Identification of non-annotated SVs 
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Since OR loci are characterized by high density of annotated TEs which contribute to 
high genomic complexity, our initial goal was to identified the presence of non-
annotated genomic variations in Olfr2 locus.  
Variation discovery was performed with Pindel tool on Illumina reads for each PCR 
amplicon, indeed amplicons were sequenced as single units of the Olfr2 locus. 
Overall in the 50 kb locus, we identified 2400 deletions, 34 inversions, 407 tandem 
duplications and 806 insertions (Table 3.1). 
Interestingly all the variations were found in a “heterozygous condition”, meaning 
that for each variation we found only a small percentage of reads (“alternate reads”) 
supporting the non-annotated variant, while a majority of the reads (“reference reads”) 
supported the invariant reference sequence.  
 
 
Table 3.1. Number of Pindel variations identified in Illumina samples. A complete list of CNVs 
indentified with Pindel in Illumina reads per each sample is shown. “MDAV_and_MDAXI” shows 
variations shared by both MDA biological replicates; “MDAV_and_MDAXI_and_OE” shows variation 
shared by all the three samples. 
  
Figure 3.9. Number of Pindel variations per sample. Number of Pindel variations found in both MDA 
samples (green) and those found in common between MDA and OE sample (yellow) are compared. 
We identified the number of variants for each sample combination (Table 3.1). In 
order to reduce false positives due to possible MDA artifacts we filter starting Pindel 
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dataset considering only those variants found in both MDA replicates (MDA V and 
MDA XI). We then compared the number of variants present only in both MDA 
replicates with those common between MDA and OE samples. For each category, we 
observed how the number of MDA-specific (present only in both MDA V and XI) and 
common variations (present in both MDA and OE samples) are comparable (Figure 
3.9). 
3.3 Genomic deletions in Olfr2 locus 
Since deletions were the most abundant variation found in the Olfr2 locus, we 
decided to start performing validation analysis on this category. In Table 3.2, the 
distribution of deletions among different samples is shown. 
 
 
Table 3.2. Number of Pindel deletions in Illumina samples. A complete list of Pindel deletions found 
in different Illumina samples, per each amplicon, is shown. “MDAV_and_MDAXI” shows variations 
shared by both MDA biological replicates; “MDAV_and_MDAXI_and_OE” shows variation shared by 
all the three samples. 
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Figure 3.10. Number of Pindel deletions per amplicon. Number of Pindel deletions for each Olfr2 
locus amplicon are shown (Top panel). Average number of Pindel deletions in 5’ amplicons (1-5) is 
compared with average number of Pindel deletions in 3’ amplicons (6-11) (Bottom panel). 
In agreement with a general higher coverage for the amplicons upstream the Olfr2 
TSS (1-5) compared with the coverage of those downstream (6-11) (data shown in 
Appendix), the highest number of deletions was found at the 5’ of the Olfr2 coding 
sequence (Figure 3.10, bottom panel). 
As expected amplicon 6, which contains the Olfr2 coding region, presented a very 
low number of deleted sequences, suggesting that the most conservative part of the 
locus is characterized by a low genomic variability (Figure 3.10, top panel). 
 
General length frequency distribution of all the deletions found in Olfr2 locus is 
represented in Figure 3.11. As anticipated, deletion length is overall distributed in a 
range within 50 and 5000 bp. Moreover, we observed four frequency peaks, the first 
within 50 and 300 bp, two peaks around 2000bp, and finally a peak around 4500 bp 
(Figure 3.11, left panel).  
 
Results 
 
 65 
 
Figure 3.11. Frequency of deletion length distribution. Frequency of length distribution for all Pindel 
deletions is shown (Left panel). Normalized average length of deletions for each amplicon is shown 
(Right panel). 
Interestingly, looking at single amplicons we can observe that, on average, the longer 
deletions are located in the 5’ amplicons while the deletions in the 3’ amplicons are 
shorter (Figure 3.11, right panel). All the amplicons have a similar length ranging from 
3500 bp to 5500bp except for amplicon 2.2 which was much shorter than the others, 
about 400 bp. 
 
 
 
 
3.3.1 Validation of Pindel deletions with Pac Bio long reads 
The first validation of deletions found in Illumina reads was performed taking 
advantage of Pac Bio reads. Pac Bio sequencing is characterized by higher percentage 
of sequencing error (about 14 %) compared with Illumina, but it is not affected by 
sequencing amplification bias, since it is based on single molecule sequencing.  
Each Pindel deletion supported by Illumina reads was checked for the presence of 
additional supporting Pac Bio reads (Figure 3.12).  
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Figure 3.12. Representative example of a Pac Bio read supporting a Illumina deletion. UCSC 
Genome Browser 8 kb screenshot of a 4kb Pindel deletion found in Illumina reads and supported by 
PacBio read IL, Illumina read; PB, Pac Bio read; del, deleted region.  
Deletions in amplicon 2 (for technical reason previously explained), 6 and 8 did not 
have any Pac Bio supporting reads.  
For all the other amplicons, different Pindel deletions supported by the same PacBio 
read were considered as a same unique deletion, therefore the original number of total 
deletions found in Illumna was drastically reduced (Table 3.3). Overall, only 2% (55 out 
of 2400) of all the Pindel deletions found in Illumina reads was still supported by Pac 
Bio reads. This result could find two possible explanations. One possibility is that a 
high fraction of Illumina deletions was sequencing artifacts, a second option is that Pac 
Bio sequencing did not reach saturation. 
 
Table 3.3. Number of Pindel deletions supported by Pac Bio (PB) reads. Number of PB-supported 
deletions in Illumina samples per each amplicon is shown. MDAV_and_MDAXI shows variations shared 
by both MDA biological replicates; MDAV_and_MDAXI_and_OE shows variation shared by all the 
three samples. 
In order to have an overview of the Pac Bio supported deletion distribution 
throughout the 50kb Olfr2 locus, a condensed representation of the deletions pattern for 
each amplicon is shown in Figure 3.13. 
 
Figure 3.13. Pac Bio-supported deletions distribution in Olfr2 locus. UCSC Genome Browser 
representation of Pac Bio-supported deletions in 50 kb Olfr2 locus. Number of amplicons harboring the 
deletions are indicated in red. For each deletion, a “dense” representation is indicated with black 
rectangles. Olfr2 coding sequence is highlighted in blue. 
Looking at the frequency of deletion length distribution, after Pac Bio filter, we note 
that the number of very small and very long Illumina deletions (<100 bp and >4000 bp) 
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was reduced, the majority of deletions having a length ranging from ca. 2000 to 4000 
bp.  
Focusing on single amplicons, interestingly we can observe that the longer deletions 
were maintained in the 5’ amplicons compared with the 3’ ones (Figure 3.14, right 
panel). 
 
 
Figure 3.14. Frequency of length distribution for Pac Bio validated deletions. Frequency of length 
distribution for all Pac Bio-supported deletions is shown (Left panel). Normalized average length of 
deletions for each amplicon is shown (Right panel). 
Comparing deletions distribution among samples, we observed that 19 out of 55 
deletions were present in both MDA replicates but not in OE samples, suggesting they 
could be those implicated in Olfr2 expression. The majority of MDA-specific deletions 
were located in amplicon 3, while amplicon 1 presents the highest number of common 
deletions (Figure 3.15). Nevertheless, we cannot exclude that MDA specific deletions 
are artifacts since we did not find any OE read supporting them. Importantly, the risk of 
MDA artifacts can be excluded for the 11 deletions shared by both MDA and OE 
samples.  
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Figure 3.15. Number of Pac Bio-supported deletions per sample. Number of Pac Bio-supported 
deletions in MDA samples (green) and in MDA and OE samples (yellow) is shown for each amplicon. 
 
Finally, for all the Pac Bio supported deletions which were shared by both MDA 
replicates and OE sample (common deletions), we calculated the Illumina coverage 
(“reference reads”/ “alternate reads” x 100) comparing the three samples (OE, MDA V 
and MDA XI) (Figure 3.16). Interestingly, for the majority of Pac Bio-supported 
common deletions, MDA coverage (in at least one MDA replicate) was higher than OE 
coverage. In particular, the deletion “2898_3887” in amplicon 3 was characterized by a 
very high coverage in one MDA replicate (MDA XI) (Figure 3.16). 
 
 
Figure 3.16. Illumina coverage for Pac Bio-supported common deletions. Percentage of Illumina 
sample coverage is shown for each deletion shared by MDA and OE. Number on x-axis indicated the ID 
of each deletion for each amplicon. 
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3.3.2 Independent technical PCR validation of Pindel deletions 
In parallel to Pac Bio validation, Pindel deletions were validated independently by 
qualitative end-point PCR. We decided to perform PCR validation as independent 
approach in order to overcome the problem of potential lack of saturation for Pac Bio 
sequencing. In other words, if we considered as true only the deletions supported by 
both Illumina and Pac Bio reads we could have missed the portion of putative true 
Pindel deletions not detected by Pac Bio sequencing. Therefore, we decided to select the 
deletions to be validated among those called by Pindel in the MDA Illumina data 
regardless of their presence in the Pac Bio ones. 
However, one technical problem for designing PCR assay was the high number of 
Pindel deleted sequences, often differing for just 1 nucleotide and often overlapping 
each other (Figure 3.17, top panel). Therefore, given the complex deletion pattern for 
each amplicon, we designed validation primers on a consensus of Illumina reads at the 
5’ and 3’ of each deletion (Figure 3.17, bottom panel). With this approach we aimed at 
detecting by PCR at least the most covered deletions.  
 
 
Figure 3.17. Pindel deletions and Illumina consensus reads. Top panels: two representative examples 
of complex Pindel deletion patterns in amplicon 1 and in amplicon 3. Bottom panels: Illumina consensus 
reads supporting Pindel deletions in amplicon 1 and amplicon 3. Green arrows indicate validation 
primers; green rectangle indicates the region amplified with validation assay, consisting of different 
Pindel deletions. Detailed Repeat Masker annotation for different repetitive elements is shown above the 
Illumina consensus reads. 
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Additional challenge in designing specific validation primers was due to the high 
density of repetitive elements overlapping the deleted sequence (Figure 3.17, bottom 
panels). Nevertheless, we could design at least one specific PCR validation assay for 
amplicon 1, amplicon 3, amplicon 4 and amplicon 5. 
Technical PCR validations were performed on amplified PCR products preserved 
from the initial long PCR amplicons (MDA and OE) which were sent for Pac Bio and 
Illumina sequencing (Figure 3.18). 
Putative “deleted” PCR bands were extracted from agarose gel and re-sequenced by 
Sanger sequencing. Interestingly, for each PCR reaction we were able to amplify both 
the deleted and the non-deleted sequence, although with variable efficiency (Figure 
3.18). 
 
 
 
Figure 3.18. Deletion PCR validation results. Green rectangles indicated putative deleted and non-
deleted bands for each validation assay. “MDA_PB” and “OE_PB”= MDA and OE PCR amplicon 
sample sequenced by Pac Bio; “MDA_ill” and “OE_ill”= MDA and OE PCR amplicon samples 
sequenced by Illumina. 
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An example of Sanger sequence of an independent PCR product, supporting the 
deletions according to the Illumina reads pattern, is shown in Figure 3.19.  
 
 
 
Figure 3.19. Example of Sanger sequence supporting Pindel deletions. UCSC Genome Browser 5kb 
screenshot: representative Sanger sequence is indicated by green arrows; Illumina reads supported by 
Sanger sequence are indicated by orange arrows. 
Confirmed Sanger sequences were then intersected with the coordinates of Pindel 
deletions. From this intersection we could identify the deleted sequences matching with 
the Sanger sequence of the DNA band amplified by validation primer assays (Figure 
3.20). 
 
Results 
 
 72 
 
Figure 3.20. Sanger sequences supporting selected Pindel deletions. Sanger sequences for amplicons 
1, 3, 4 and 5 are shown with black rectangles and indicated by the yellow arrows. Red arrows indicate the 
Pindel deletions supported by Sanger sequences. Detailed Repeat Masker annotation is activated. 
 
So far we were able to validated 6 different deletions in about 20 kb upstream the 
Olfr2 coding sequence. Validated deletions were found in amplicon 1, 3, 4 and 5 (Table 
3.4).  
Amplicon 3 deletion was supported in OE sample by only 1 read (under the Pindel 
coverage threshold of 5 reads), for this reason it was initially classified as MDA-
specific deletion. 
Interestingly, 3 out of 6 PCR validated deletions were also supported by Pac Bio 
reads. Moreover, deletions in amplicon 1 and amplicon 3, which were shared between 
OE and MDA samples, had a higher coverage in MDA compared with OE. Thus 
suggesting they could be involved in Olfr2 expression without the risk to MDA 
artifacts. For these reasons we focused on these deletions for further independent 
validations.  
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Table 3.4. PCR validated deletions summary information. For each deletion validated by PCR all the 
related information is summarized. PCR_validated= sample where deletion was validated by PCR; 
ID_Pindel (best match) = ID of Pindel deletion which is supported by Sanger sequence with the highest 
nucleotide precision; deletion_bp= length of deleted sequence; NON-del_band_bp= length of non-deleted 
sequence; expected_del_band= length of expected deleted PCR band; cov_MDA V% , MDAXI%, OE 
(Ref/Alt)= Illumina reads coverage for each sample calculated by the number of alternate reads (Alt), 
supporting the deletion and the number of reference reads (Ref), supporting the reference sequence; MDA 
and OE-PB reads= number of supporting Pac Bio reads for sample. 
3.3.3 Amplicon 3-deletion additional validations 
So far, we further validate amplicon 3 deletion from bulk OE gDNA and from total 
MDA amplified DNA (starting material before PCR amplification). With this approach 
we could exclude even the possibility of being looking at PCR artifacts, possibly 
produced during the initial Olfr2 locus PCR amplification (Figure 3.21).  
 
Figure 3.21. Additional PCR validation for amplicon3-deletion. Validated amplicon 3-deletion bands 
are shown for three MDA replicates (I, X, XI) and from total gDNA extracted from OE (bulk OE DNA) 
in the green rectangle. 
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3.3.4 Deletions distribution with respect to Olfr2 locus repetitive 
elements 
In order to assess if LINE-1 elements could be involved in deletions formation, we 
start investigating how deletions are distributed with respect to different classes of 
annotated repetitive elements in 50 kb of Olfr2 locus. Within region analyzed, 80 
different repetitive elements are annotated by Repeat Masker, covering a total of 34805 
bp. The remaining 15191 bp consist of genomic DNA. Among these repeats, 12 LTR 
(3944 bp), 11 SINE (1594 bp) and 29 LINE (27341 bp) fragments are annotated (Figure 
3.22).  
 
Figure 3.22. Representation of repetitive elements annotated in 50kb Olfr2 locus. UCSC Genome 
Browser screenshot of 50 kb Olfr2 locus. Black rectangles indicate a “dense” UCSC representation of 
annotated repeats.  
In order to normalize for differences in locus occupancy by different classes of 
repeats, we calculated percentage of bases covered by deletions. Pindel deletions 
covered 98 % of LINE, 85 % of SINE and 79 % LTR occupied regions (Figure 3.23). 
Interestingly, when considering the deletions supported by both Illumina and PacBio 
reads, the loss of LINE sequences (from 98 to 77% of bp covered) was less pronounced 
compared with SINEs and LTRs coverage (from 85 to 46% and from 79 to 36% of bp 
covered, respectively).  
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Figure 3.23. Repeat coverage for Olfr2 deletions. Deletions bp coverage for different classes of 
repetitive elements is shown. LINE coverage is represented in red, LTR coverage in green and SINE 
coverage in blue. For each class, the number of bp covered in the locus (first column for each group), the 
number of bp covered by Pindel deletions (second column), and the number of bp covered by Pindel 
deletions supported by Pac Bio (PB) reads (third column), is shown. 
3.3.5 Direct repetitive sites (DRSs) delimiting validated deletions 
Looking more in details at the six validated deletions we noticed that they were all 
 characterized by the presence of two annotated short direct repetitive sequences at 
the 5’ and 3’ of the deletion, respectively. Interestingly, the resulting deleted sequence 
harbors only one of the two repeat sites (Figure 3.24).  
 
 
Figure 3.24. Common structural pattern of validated deletions. Non-deleted and resulting deleted 
sequences are shown. Black filled arrows represent validation primers, violet rectangles and yellow 
rectangles represent sequences at 5’ and 3’of the deletion, respectively. DRSs are highlighted in light 
blue. 
We referred to these peculiar repeats as “Direct Repetitive Sites” (DRSs), 
interestingly they were annotated on different LINE-1 elements located at the deletion 
borders. 
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A representative example of amplicon 3 deletion pattern and DRSs sites is shown in 
(Figure 3.25).  
Looking at the amplicon 3-deletion, we noticed that the 3555 bp deleted sequence 
was characterized by several annotated LINE-1 elements harboring different alternative 
LINE-1 EN cutting sites. In particular, “5’-TTAGAA-3’” and “5’-CTAAAA-3’” sites 
were repeated once, “5’-TTGAAA-3’” and “5’-TTAAAG-3’” were repeated three times 
in the deleted regions. 
 
 
Figure 3.25. Structural conformation of amplicon 3-deletion. Left panel: reference, non-deleted 
sequence. Sequences at the 5’ and 3’ of the deletion are highlighted in violet and yellow, respectively. 
Lentgh of deleted sequence is indicated. DRSs are highlighted in light blue. Forward and reverse 
validation primers are indicated in bold font. Right panel: non-annotated deleted sequence. Portion at the 
5’ and 3’ of the deletion are highlighted in violet and yellow, respectively. The left DRS is highlighted in 
light blue. Forward and reverse validation primers are indicated in bold font. 
We hypothesized a deletion supporting mechanism mediated by the presence of 
DRSs, flanking the deletion, and by LINE-1 EN cutting sites within the deletion. 
According to this mechanism, deletions could be generated after LINE1-EN-dependent 
DSB repair, mediated by homologous recombination between DRSs. 
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3.4 ChIP-Seq analysis of endogenous -H2AX in mouse OE 
and L 
Given the potential involvement of endogenous LINE1-EN-dependent DSBs in the 
deletions formation, we start investigating the expression and the genomic localization 
of a DSBs marker (-H2AX) in mouse tissues, under physiological conditions. 
3.4.1 Preliminary results: endogenous -H2AX expression in mouse 
tissues 
Before investigating endogenous -H2AX genomic distribution in mouse OE we 
needed to assess whether the phosphorylated form of the histone was detectable in 
different mouse tissues under physiological conditions. Therefore, we performed 
western blot for -H2AX in two neural tissues (OE and cerebellum (Cer)) and two non 
neural ones (liver (L) and kidney (K)). Each tissue was analyzed at the two different 
ages of 6 days and 30 days after birth (Figure 3.26). 
 
 
Figure 3.26. WB anti-H2AX in different mouse tissues. Whole tissue protein lysates from C57BL/6J 
mice at p6  (left panel) and 1m (right panel) were analyzed for endogenous -H2AX expression. Cer, 
cerebellum; K, kidney;OE, olfactory epithelium; L, liver. Phosphorylated form of H2AX (-H2AX) is 
shown at 17 kDa (yellow square) and phosphorylated plus monoubiquitinated H2AX (Ub-H2AX) is 
shown at 25 kDa (in the green square). Total H2AX and -actin were developed on the same membrane. 
At both the ages analyzed, with the same anti--H2AX antibody we were able to 
detect two different and specific signals, the expected phosphorylated H2AX (-H2AX) 
at 17 kDa and the mono-ubiquitinated and phopshorylated form of the histone (Ub--
H2AX) at 25kDa. In general, all the samples in all the conditions showed a stronger Ub-
-H2AX signal compared with -H2AX. Interestingly, the Ub--H2AX was more 
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intense in non-neural tissues compared with neural ones, while the -H2AX signal 
presented an opposite trend. 
Additional replicas and further experiments should be performed to better understand 
the biological meaning which could underlie tissue differences in Ub--H2AX/-H2AX 
ratio. 
3.4.2 General characterization of -H2AX peaks   
In order to investigate how -H2AX distributes in the mouse genome we performed a 
chromatin immuno-precipitation (IP) and sequencing experiment in C57BL/6J mice, 
analyzing OE at two ages (6 days (p6), 1 month (1m), after birth) and liver (L) at p6. 
For each IP experiment, OE and L were pooled together from about 10 mice in order to 
get a suitable quantity of chromatin. 
For each condition, we sequenced two different biological IP replicates each derived 
from different pools of mice. In parallel we sequenced a same quantity of INPUT 
sample (total starting chromatin) as control (Table 3.5). 
 
 
Table 3.5. ChIP-Seq samples sequenced by Illumina sequencing. For each sample two biological 
replicates (A and B) were sequenced. Input chromatin for each sample was sequenced as background 
control. 
Peak calling was performed by SICER tool (see details in Methods and Materials). 
To obtain a representative set of ChIP-seq peaks for each biological condition (L at p6, 
OE at p6 and OE at 1 month) we considered the intersection of the peak sets obtained in 
the two replicates and these were used in subsequent analyses. The number of peaks 
called for each sample, their length and the number of intersection-peaks are reported in 
Table 3.6. 
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Table 3.6. ChIP-seq peak calling output. Peaks were called with EPIC tool, number of peaks and peak   
lengths for each biological replicate are indicated. For each sample peaks from two biological replicates 
were intersected and intersected sample datasets were used in following analysis.  
From an intersection among the peak datasets resulted that almost 6000 peaks were 
shared among the three samples, 2000 peaks were found only in OEp6, 6000 only in 
OE1m and almost 12000 peaks were exclusive for Lp6. 
For all the following analysis we used peak datasets resulted from peaks intersection 
between two biological replicates for each sample. 
A subset of shuffled peaks was generated as background control dataset to use in all 
the analysis.  
-H2AX peaks genome distribution 
To visualize -H2AX peaks distribution in mouse genome we used NEBULA, a tool 
able to calculate for each sample the proportion of peaks falling within different 
genomic features (e.g. within genes, intergenic, 5’UTRs ect).  
For both OE and L datasets about the 90% of peaks fall within the regulatory and 
transcribed portion of the genome (gene bodies, promoters, 5’UTRs and enhancers), 
while only a 10% fall in intergenic regions (Figure 3.27).  
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Figure 3.27. ChIP-seq peaks genome annotation. Peaks genome distribution was performed with the 
bioinformatics tool NEBULA; the genomic regions were considered with respect to gene start site (TSS). 
For each sample the proportion of peaks falling in each genomic region is shown. NEBULA legend: Gene 
Down=gene downstream (3’UTR), Ehn= enhancer, Imm.Down.=Immediate downstream (5’UTR), 
Interg.=intergenic, Intrag.=intragenic, Prom=promoter. Real sample peaks were represented in blue, 
shuffled peaks were represented in grey. 
-H2AX peaks distribution with respect to Transcription Start Sites (TSSs) 
Using NEBULA, we were able to investigate peaks distribution with respect to 
annotated TSSs. Shuffled peaks did not show any enrichment at TSSs, while IP sample 
peaks were enriched within 0 and 10kb downstream the TSS (Figure 3.28).  
L sample seems to have sharper distribution at TSSs than OE samples, some 
differences between OE and L peaks distribution at TSSs could be due to poorer TSSs 
annotation in OE tissue compared with L. 
Results 
 
 81 
 
Figure 3.28. ChIP-Seq peaks distribution around TSS. Peaks genome distribution with respect to 
annotated TSS was performed with the bioinformatics tool NEBULA. For real and shuffled peak datasets 
peak density was plotted with the distance from annotated TSSs. 
-H2AX peaks localization at GpC islands 
Given the poor characterization of -H2AX in physiological conditions, we 
wondered whether identified sites of -H2AX enrichment identified co-localize with 
CpG islands, as it could be a feature of -H2AX peaks to prefer being deposed on CpG 
islands or avoid them.  
 
 
Table 3.7. Percentage of peaks overlapping CpG islands. For each sample the percentage of peaks 
overlapping CpG islands is shown. 
We observe that about 20 to 24% of the peaks identified overlap at least one 
annotated CpG island (Table 3.7). This is in sharp contrast with the set of randomly 
created ChIP-seq peaks, only about 3% of which overlaps a CpG island. This suggests 
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that at least part of the H2AX-bound DNA in physiological conditions is associated to 
CG rich regions.  
3.4.3 -H2AX peaks functional annotation 
Gene Ontology enrichment analysis 
In order to assess any functional enrichment for -H2AX peaks we took advantage of 
the software GREAT, a bioinformatics tool specific for ChIP-Seq peak annotation and 
gene ontology (GO) enrichment. In particular, we looked for “Biological process” 
enrichment of each sample dataset (foreground dataset) against total number of sample 
peaks (background dataset). Surprisingly, L and OE sample peaks turned out enriched 
for different biological processes (Figure 3.29).  
 
 
Figure 3.29. ChIP-seq peaks enrichment for GO Biological Process. “Biological Process” GO 
enrichment analysis was performed by GREAT tool. Top 10 GO categories were shown for each sample. 
For each peaks the nearest TSS was annotated. Only p-values < 0.0001 were considered in the output 
results. 
Some interesting processes enriched in L were “interferon-gamma biosynthetic 
process”, “common bile duct development” and “negative regulation of hepatocyte 
growth biosynthetic process”; OE p6 was enriched for biological processes linked to 
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“axon choice point recognition” and “collateral sprouting”; surprisingly “sensory 
perception of smell” was the only biological function enriched in OE 1m. 
Overall GO results suggested some tissue specificity for peaks functional annotation. 
 
3.4.4 -H2AX peaks distribution within different regulatory sites 
To compare peaks distribution with respect to different regulatory sites, we took 
advantage of publicly available datasets, looking for the best possible match with OE 
and L tissues. While L datasets were readily available, we couldn’t find much data for 
the OE: we used instead olfactory bulb, cortex and whole brain tissues, as the closer 
tissue types we could find data for. 
CTCF, RNA Pol II and DNAseI regulatory sites 
 
Figure 3.30.ChIP-Seq peaks overlap within DNAse,CTCF and PollII regulatory sites. Results 
obtained from mouse liver datasets are shown. lip6= liver p6 peaks; shuff= shullfe peaks. For each 
sample the percentage of peaks falling within 1 kb from a regulatory site is shown. 
The majority of the peaks (about 70-75%) for each sample fell within 1kb of a 
DNAseI hypersensitive site (Figure 3.30), confirming what obtained in the work of 
Lensing and colleagues (Lensing et al., 2016). This result suggests a link between 
regulatory chromatin and genome instability. Looking at shuffled dataset, this was true 
only for 25% of peaks.  
Results 
 
 84 
A similar analysis was performed to investigate peak distribution with respect to 
CTCF binding sites. CTCF is a regulatory protein responsible for the formation, 
together with cohesion factors, of chromatin loops between different parts of the 
genome. Moreover, CTCF can be involved in different gene regulatory pathways acting 
as repressor or activator of gene transcription. Interestingly we observed that about 30% 
of the peaks fall within CTCF binding sites, for each sample (Figure 3.30). 
We further investigated -H2AX peaks distribution with respect to RNA Pol II 
binding sites. About 10-15% of peaks for each sample fall within Pol II binding sites 
suggesting that a subset of H2AX peaks could be involved in transcription (Figure 
3.30). 
Similar results were obtained comparing the peaks with brain and olfactory bulb 
datasets as presented in the Appendix (Figure-B 5).  
Chromatin segmentation analysis 
To gain further insight about the localization of -H2AX with respect to other 
chromatin marks, we used publicly available ChIP-seq data on PolII, CTCF and 7 
histone modifications to create a 10-state segmentation of the mouse genome based on 
combinatorial re-occurrence of subsets of the marks under analysis (see details in 
Methods and Materials).  
 
 
Figure 3.31. Chromatin segmentation of mouse genome. 10-state segmentation of mouse genome. 
Publicly available ChIP-seq data on PolII, CTCF and 7 histone modifications were used. White and blue 
colors represent, respectively, no enrichment and tha maximum enrichment. 
 
As summarized above, this means in practice that each position within the chromatin 
is assigned to one of 10 possible states, each one characterized by enrichment in one or 
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more chromatin marks (with the exclusion of state 6, for which none of the chromatin 
marks is enriched) (Figure 3.31). 
 
To create a human readable annotation of the identified states and an interpretation 
of their meaning, we created a summary of the marks enriched for each state and 
corresponding function and used these to formulate a short description for the state itself 
(Table 3.8). 
 
 
Table 3.8. Summary of marks enriched for each state. For each chromatin state, enriched mark, level 
of enrichment, mark description and short state description are indicated. +++= maximum enrichment; += 
minimum enrichment; NA= no enrichment. 
We used built-in features of the ChromHMM framework (see details in Methods and 
Materials) to annotate the -H2AX peak sets. As shown in Figure 3.32, the three real 
peak sets show similar enrichment patterns, with states 4, 2 and 7 being the ones with 
the strongest enrichment. This is consistent with the observation that a very large 
proportion of the peaks is located in gene bodies and suggests that this deposition 
pattern is linked to a regulatory function of -H2AX within the gene bodies in 
physiological conditions. As expected, and consistently with previous observations, for 
the set of randomly distributed peaks no enrichment is detected for all states. 
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Figure 3.32. Sample fold enrichment among different chromatin states. White and blue colored 
squares represent, respectively, no enrichment and tha maximum enrichment. 
Peaks overlapping active enhancers 
Given that the combination of H3K27ac and H3K4me1 marks active enhancers 
(Calo and Wysocka 2013) we extracted the set of peaks overlapping chromatin 
segments in state 3 (Table 3.9). 
 
 
Table 3.9. Percentage of peaks overlapping active enhancers. For each sample, the percentage of 
peaks in overla with state-3 marks (active enhancers) is indicated. 
This suggests that at least part of the -H2AX signal co-localizes with putative 
enhancers. 
 
3.4.5 -H2AX peaks correlation with expression 
Pol II-overlapping -H2AX peaks correlation with OE and L active TSSs 
We first investigated whether the ca. 15% of -H2AX peaks overlapping Pol II 
binding sites were also in overlap with an active TSS, in OE or L datasets (see details in 
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Methods and Materials for information about the expression datasets used). For each 
sample, the number of Pol II-overlapping peaks associated to an active TSS in L and 
OE datasets is shown in Table 3.10. 
 
 
 
Table 3.10. Pol II-overlapping peak correlation with active TSSs. The column “Pol II-overlapping 
peaks” indicates the number of -H2AX peaks overlapping PolII binidng sites; the column “L_TSSs-
overlapping peaks” indicates the Pol2-overlapping peaks that were also associated to a TSS active 
according to the FANTOM5 liver dataset (numbers in brackets indicate the corresponding percentage out 
of the total number of Pol2-associated peaks); similarly the column “OE_TSSs-overlapping peaks” 
indicates the number of PolII-associated peaks overlapping one active TSS according to the OE dataset. 
As expected there is a very high concordance between the peaks overlapping Pol II 
signal and peaks overlapping an active TSS (about 71 to 75 %). This is remarkably high 
given that the techniques and the samples used are fairly different. 
-H2AX peaks correlation with OE and L active TSSs 
Comparison with TSSs active in the OE 
OE-active TSSs overlapping -H2AX peaks belonging to any of the three considered 
peak sets have higher expression levels with respect to OE-active TSSs that do not 
overlap -H2AX peaks. We do not observe the same effect for OE-active TSSs 
overlapping a mock-up set of peaks randomly distributed along the genome (Figure 
3.33, left panel). 
Even though there are no major differences between expression levels of OE-active 
TSSs within/outside the three peak sets considered, we observe a trend further 
suggesting at least a certain degree of tissue specificity (Figure 3.33, right panel). 
 
Results 
 
 88 
 
Figure 3.33. ChIP-seq peaks comparison with active OE-TSS. Left panel: per each sample, the 
expression values of OE-active TSSs falling within and without  the peaks are compared. Right panel: 
fold induction of OE-active TSSs expression values is shown for each sample. 
Comparison with TSSs active in L 
A similar comparison performed in L tissue doesn’t give as a stark evidence that in 
general TSSs active in L overlapping -H2AX peaks have higher expression than those 
located more far away from the peaks (Figure 3.34). We cannot exclude that the weaker 
effect might be due to technical reasons. Possible explanations include the fact that: the 
nature of CAGE data is very different from RNAseq data, there are less samples and 
therefore the signal is likely less robust, the age of the mice from which the liver was 
derived is fairly different from what was used for ChIP-seq library preparation. 
 
Figure 3.34. ChIP-seq peaks comparison with active L-TSS. Left panel: per each sample, the 
expression values of L-active TSSs falling within and without  the peaks are compared. Right panel: fold 
induction of L-active TSSs expression values is shown for each sample. 
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ChIP-seq signal is stronger for peaks overlapping active TSSs in both L and OE 
In addition, we evaluated peaks correlation with active TSSs considering peak p-
values, which give a quantification of the strength of the corresponding ChIP-seq peaks. 
We first compared the p-values of ChIP-seq peaks overlapping active TSSs in both L 
(Figure 3.35,top panels) and OE (Figure 3.35, bottom panels). It is evident that peaks 
overlapping active TSSs have more significant p-values associated to them. 
 
 
 
Figure 3.35.Comparison of peaks p-values with respect to active-TSSs. Top panels are referred to 
TSSs active in L and bottom panels to TSSs active in OE. For each sample the p-values of peaks 
associated to a TSS is compared with the p-values of peaks not associated to a TSS. 
ChIP-seq peaks overlapping active TSSs in both L and OE 
Since there is a notably similar proportion of TSSs overlapped in the comparison 
with the two distinct expression datasets, we investigated the number of -H2AX peaks 
overlapping active TSSs, in both OE and L datasets. 
Checking the expression data, we can say that there is in general a high overlap 
between peaks overlapping active TSSs in the two datasets (Table 3.11). That is, most 
-H2AX peaks that overlap an active TSS in the L dataset overlap an active TSS in the 
OE dataset. Given that -H2AX peaks are not extremely long, this means in most cases 
that the same expressed gene is overlapped. 
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Table 3.11. Peak overlap with active TSSs. The column “L_TSSs-overlapping peaks” indicates the 
number of -H2AXpeaks that were associated to a TSS active according to the FANTOM5 liver dataset; 
similarly the column “OE_TSSs-overlapping peaks” indicates the number of -H2AXpeaks that were 
associated to a TSS active according to the RNA-seq OE dataset; the column “L and OE_TSSs-
overlapping peaks” indicates the number of -H2AXpeaks that were associated to a TSS active in both L 
and OE datasets. The last column expresses the percentage of -H2AXpeaks that were associated to a 
TSS active in both L and OE datasets. 
3.4.6  -H2AX peaks enrichment for different classes of repeats 
In agreement with the previously observed -H2AX signal distribution within the 
transcribed portion of the genome, we observed a clear enrichment of -H2AX peaks for 
SINE elements. Among different classes of repetitive elements, SINEs are indeed those 
associated with actively transcribed genes (Figure 3.36). 
 
 
Figure 3.36. ChIP-seq peaks enrichment for different classes of repetitive elements. For all the 
samples the percentage of peaks coverage (bp) for each class of repeats is shown. Real peaks are shown 
in red and random peaks are shown in green. Black lines represent standard deviation. 
 
 
 
3.4.7 -H2AX peaks within gene clusters 
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Chip-seq analysis of CTCF binding sites in human fibroblasts showed that CTCF-
depleted domains included clusters of related genes that are transcriptionally co-
regulated, supporting a role for CTCF-binding sites acting as insulators. Gene clusters, 
among which OR-clusters, are surrounded by a pair of consecutive CTCF-binding sites 
in the genome (Kim at al., 2006).  
Interestingly, we previously observed that 30% of H2AX peaks overlapped with 
CTCF binding sites (Figure 3.30). Therefore, we wanted to verify if 30% of CTCF-
overlapping -H2AX peaks follow the same CTCF localization with respect to olfactory 
clusters. We compared the distribution of CTCF peaks (public dataset) and CTCF-
overlapping H2AX peaks, with respect to OR gene clusters considering different 
intervals, within and outside the clusters.  
Overall, as expected, CTCF-overlapping H2AX peaks from both OE and L were 
depleted inside olfactory clusters but preferentially distributed outside the co-regulated 
regions, thus confirming their distribution according to CTCF signal (Figure 3.37). 
 
 
Figure 3.37. CTCF-overlapping -H2AX peaks distribution with respect to OR-gene clusters. 
CTCF-overlapping peaks were intersected with olfactory clusters to see the % of H2AX peaks falling 
inside the clusters and within different range of intervals outside the clusters. Too few peaks fall within 0 
and 100 kb to be visible in the graphic. A parallel analysis was performed with CTCF peaks from OB 
public dataset (OLFB_CTCF). 
-H2AX peaks within Olfr2 cluster 
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Finally, we investigated further how all H2AX peaks were distributed with respect 
to the OR cluster where Olfr2 is located on chromosome 7 and which was extensively 
studied in the structural variation analysis. As expected the peaks were depleted inside 
the 1Mb Olfr2 cluster but preferentially distributed outside it (Figure 3.38). 
Interestingly, the only exception was one OE1m H2AX peak which falls inside the 
Olfr2 locus. In particular, it was located between amplicon 3 and amplicon 1 validated 
deletions, overlapping amplicon 2 coordinates. (Figure 3.39). The peak is characterized 
by a high number of supporting reads, suggesting it represents a real signal. 
 
 
 
Figure 3.38. H2AX peaks distribution with respect to Olfr2 cluster. UCSC Genome Browser 1Mb 
screenshot showing the entire Olfr2 cluster on chromosome 7. OE -H2AX peaks are indicated by the 
blue (OEp6) and green (OE1m) arrows. No L peaks were detected in the same region. Red rectangles 
indicated the Olfr2 validated deletions and red arrow indicated Olfr2 coding region. 
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Figure 3.39. OE -H2AX peak localization with respect to validated deletions. Amplicon 1 and 
amplicon 3-deletions are indicated by red arrows; OE -H2AX peak is indicated by green arrow.   
ChOE1m A and B pileups show the peak-supporting reads for each ChIP-sample replicate. Pileup of 
reads in the two sample replicates (OE 1m A and OE 1m B) are indicated.
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4 Discussion 
Here we discuss our results. In particular, we will focus our attention on LINE-1 
retrotransposition in OE, LINE-1 enrichment in OR loci, analysis of genomic deletions 
in Olfr2 locus and finally about endogenous DSBs in OE and L. 
4.1 LINE-1 expression and CNV in OE 
It has been demonstrated that both full length and truncated LINE-1 transcripts are 
barely expressed but detectable in several somatic human tissues like liver, prostate, 
heart muscle, and stomach (Faulkner et al. 2009). Conversely, in other somatic tissues 
as kidney, spleen and adrenal gland, LINE-1 expression is considered below the 
detection limit (Faulkner et al. 2009; Belancio et al. 2010). 
Recently, LINE-1 expression and engineered LINE-1 retrotransposition in mature 
neuronal cells have been investigated, demonstrating that engineered LINE-1 
retrotransposition can take place in non-dividing mature neuronal cells (Angela Macia 
et al. 2016). In 2014, Pascarella and colleagues demonstrated, with NanoCAGE analysis 
from OE of C57BL/6J mice at p21, LINE-1 transcription at vomeronasal (VR) and OR 
loci (Pascarella 2014). 
In agreement with these evidence, by using RT-qPCR assays, we demonstrated for 
the first time that both full length and 5’truncated endogenous LINE-1 transcripts are 
highly expressed in mouse OE compared with K and Cer from C57BL/6J mice at p21. 
RT-qPCR results were comparable for each of the three full length LINE-1 subfamilies 
analyzed (Gf, Tf and A). Consistently, looking at the total number of LINE-1 transcripts 
(ORF2 probe), their relative expression in OE was even higher. Indeed, using the ORF2 
probe we were able to detect significantly higher LINE-1 expression also in Cer 
compared with K (3.1.1). 
RT-qPCR expression results for LINE-transcripts were confirmed also by 
immunofluorescent-IHC experiments for LINE-1 ORF2 protein, comparing OE with 
Cer, K and L tissues from C57BL/6J mice at p6. The strongest ORF2 signal was 
detected in OE, where ORF2 presented a punctuate and cytoplasmatic/perinuclear 
localization in the majority of cells. Nevertheless, in some OE cells positive nuclei were 
detected. In Cer only few cells were positive for ORF2, showing a punctuate pattern 
localized both in the cytoplasm and in the nucleus. In L we detected a similar ORF2 
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pattern but with a higher background signal in the secondary antibody control. No 
signal was detected in K. 
Looking in detail at OE, ORF2 was expressed in the basal layers of OE consisting of 
stem cells and OSNs progenitor cells. Moreover, in the OE intermediate layer, where 
OSNs are located, ORF2 co-localization with OMP protein was observed by double 
IHC. ORF2/OMP co-localization suggests that the expression of LINE-ORF2 protein 
can be also supported by mature and differentiated OSNs, in agreement with results 
from the work of Macia and colleagues (Macia et al., 2016). Remarkably, ORF2 pattern 
in mouse OE resembles the ORF2 expression pattern observed in murine breast-cancer 
tissues at the early stage of tumor progression (Gualtieri et al., 2013). Overall LINE-1 
expression results were in agreement with data published by Belancio and colleagues. 
The authors, indeed, demonstrated variable expression of endogenous LINE-1 in 
somatic human tissues, with the amount of LINE-1 level in some tissues comparable to 
those detected in cancer cells (Belancio et al., 2010). 
The detection of LINE-1 transcripts can have different consequences on OE gene 
expression. Indeed, LINE-1 sequences harbor two endogenous sense promoters, at 5’ 
and 3’UTRs, respectively, and one antisense 5’promoter. In particular, Faulkner and 
colleagues showed how 5’-truncated LINE-1 sequences can function as portable 
promoters for protein coding genes thanks to the presence of endogenous promoter in 
the 3’UTR (Faulkner et al., 2009). Moreover, functional expression of LINE-1 ORF2, 
carrying a conserved EN domain, can create DSBs, thus increasing genomic instability 
in OE. 
 
Another cause of genomic instability derives from potential LINE-1 transcripts 
integration in new genomic locations (LINE-1 retrotransposition). Several works, using 
cell-based engineered LINE-1-retrotransposition assay (Muotri et al. 2005; Muotri et al. 
2010; Coufal et al. 2009) and next-generations sequencing approaches (Baillie et al. 
2011; Evrony et al. 2012; Erwin, Marchetto, and Gage 2014; Erwin et al. 2016) 
demonstrated that LINE-1 retrotransposition is not restricted to germ line and 
embryogenesis but LINE-1 elements are active and can mobilize in neuronal precursor 
cells (NPCs) during adult neurogenesis. Intriguingly, recent evidence confirmed that 
engineered LINE-1 can also mobilize in post-mitotic differentiated neurons (Angela 
Macia et al., 2016). 
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In particular, in order to assess the copy-number variation (CNV) of L1 elements in 
human tissues, Coufal and colleagues also set up a protocol of Taqman qPCR and 
applied it to different human tissues and brain regions. They estimated the presence of 
approximately 80 more L1 copies in the hippocampus (H) compared to other organs 
such as heart and liver. Overall, they observed that there is a substantial variability 
between individuals, and also that the hippocampus, probably because of its neurogenic 
niche, seems to harbor a higher copy number of LINE-1 elements compared to other 
brain regions (Coufal et al. 2009)(Richardson et al. 2014). 
In our work, we investigated LINE-1 CNV in OE, H, K and L from adult C57BL/6J 
mice. In agreement with results obtained by Coufal in human tissues (Coufal et 
al.,2009), we were able to detect an increase in both full length and 5’truncated LINE-1 
copies in H compared with L and K. Additionally, we detected the highest rate of LINE-
1 retrotransposition in OE and not in H. This result can be explained if we consider that 
OE, like H, is characterized by proliferating neuronal precursors, able to constantly 
regenerate mature OSNs. Moreover, another intriguing possibility is that part of the 
observed LINE-1 retrotransposition could be supported by differentiated OSNs as 
suggested by Macia and colleagues (Angela Macia et al., 2016) (3.1.3). 
To further investigate LINE-expression and CNV in OE, it would be interesting to 
focus on single cells, distinguishing the contribution of LINE-1retrotransposition in 
progenitors from the ones in post-mitotic differentiated cells.  
4.2 LINE-1 enrichment at OR-loci 
Zooming to OE genomic sequence, we investigated how different classes of 
annotated repetitive elements are distributed within OR-clusters.  
In 2009, Kambere and Lane performed a genomic analysis of LINE repeat content in 
OR and VR loci from five mammalian species (Kambere and Lane 2009). The authors 
demonstrated that VR and OR loci have higher LINE content than other clustered gene 
families. A LINE regulatory role in these clusters was suggested, since OR and VR 
gene clusters are not homologous and have different evolutionary origin. They showed 
that VR and OR loci resemble X-chromosome for LINE composition and segmental 
duplications.  
These results suggest that LINE could have a role in shaping the epigenetic state in 
OR and VR loci as they do favoring long-range allelic inactivation on X chromosome 
(Bailey et al., 2000 and Lyon et al., 2003). Indeed, a peculiar characteristic of OR genes 
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is the monogenic OR expression. In details, in each OSN all the OR alleles are 
inactivated except for the one which is randomly chosen (Reinsborough and Chess 
2013; Herrada and Dulac 1997). In agreement with these observations, a study of mouse 
and human monoallelically expressed genes, demonstrated they are enriched for LINE 
elements (Allen, Schmidt, and Bridle 2003). 
Concordantly with evidence obtained by Kamber and Lane, we observed that OR 
clusters are selectively enriched for LINE-1 repeats. To prove that LINE-1 enrichment 
is peculiar for OR-clusters we repeated the same analysis also for other gene clusters 
(Trypsin and Zinc Finger clusters), confirming that OR-clusters present a specific 
enrichment for LINE-1s. 
4.3 Target sequencing of 50 kb in Olfr2 locus 
We took advantage of very long MDA-amplified DNA fragments to amplify 50 kb 
within Olfr2 locus. In particular, we selected as target sequence 25kb upstream and 
downstream Olfr2 TSS as target sequence.  For sequencing we used two different but 
complementary technologies. Pac Bio RSII is a single molecule sequencing technique 
able to sequence very long reads suitable for large variations discovery. However, it 
present two limiting disadvantages: a high error rate (about 14 %) and the lack of well 
characterized Pac Bio bioinformatics tools for variation discovery. Therefore, we 
combined Pac Bio sequencing with Illumina MySeq paired-end sequencing technique. 
Illuimina has the advantages to achieve a higher coverage with a lower percentage of 
sequencing errors. Furthermore, different bioinformatics tools have been developed to 
perform variation discovery in Illumina short reads.  
 
4.4 Structural deletions in Olfr2 locus 
Somatic variations are defined as those genomic variations that occur in the soma, 
outside the germ line, and are not heritable by the following generations.  
Looking at somatic tissues, when a somatic variation occurs in a cell progenitor it 
will be inherited by all the cells of the tissue deriving from that progenitor. On the 
contrary, if a variation occurs in a post-mitotic differentiated cell it will be a unique 
feature of that cell.  
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As previously mentioned, somatic LINE-1 retrotransposition occurs mainly in NPCs 
but it can also be supported in post-mitotic differentiated neurons (Coufal et al.,2009; 
Angela Macia et al.,2016). 
The OE is characterized by heterogeneous cell populations. The basal layer consists 
of stem cells and OSN progenitor cells, while in the intermediate layer reside 
differentiated OSNs. Whether all OSNs expressing the same OR derive from the same 
neuronal progenitor is not well understood.  
Nevertheless, here we hypothesized that OR choice occurs in OSN progenitors, 
suggesting that, if a LINE-1-associated genomic variation is involved in the choice, it 
will be present in all the differentiated neurons expressing the selected OR.  
Part of the originality of this work lies in the idea to investigate the involvement of 
LINE-1-associated variations in OR-choice, taking advantage of knock-in (KI) Olfr2-
GFP mice. 
Olfr2-GFP mice, indeed, gave us the possibility to investigate structural variations 
comparing both transcriptionally active and inactive Olfr2 loci at the same time, in 
GFP-positive and in bulk OE gDNA, respectively. In order to decrease the genomic 
complexity and increase the sequencing coverage, we decided to work with the lowest 
number of cells compatible with LCM collection. 
Working with low number of cells requires whole-genome amplification (WGA) 
techniques to increase a very low DNA starting quantity. WGA techniques, in turn, can 
introduce amplification artifacts, increasing noise and false discoveries in sequencing 
analysis.  
In this work we overcome the problem of MDA artifacts using bulk OE gDNA as 
sample representative of the inactive Olfr2 loci in parallel to GFP-positive cells. Bulk 
genomic DNA extracted from OE was indeed directly used as input for long range PCR 
amplification of Olfr2 locus without any MDA amplification step.  
At the same time, bulk OE DNA represents a biological negative control since it 
consists of all OE cellular populations among which Olfr2-expressing cells represent 
about the 0.1%. 
Pindel results showed out hundreds of deletions ranging from 50 bp to about 4000 
bp, among which a high proportion was specific for MDA samples. It has to be 
mentioned that a possible limitation of our approach could be due to the relatively short 
length of Olfr2 PCR amplicons (around 5 kb) which do not allow us to identify very 
large CNVs.  
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To limit the risk of artifacts we considered as more relevant those deletions that were 
found in both MDA replicates and supported by both Illumina and Pac Bio reads.  
Independent PCR validations confirmed six deletions at the 5’ of Olfr2 TSS, among 
which two were supported by Pac Bio reads and shared by two MDA replicates.  
We focused on deletion on amplicon 3 because it was represented in MDA samples 
by the 0.5 and 0.3% of the Illumina reads in MDA V and MDA XI, respectively. 
Conversely, amplicon 3 deletion was found only in the 0.0008% of OE reads, 
suggesting a possible link with Olfr2 expression.  
Importantly, validation of this deletion in OE excluded the possibility of MDA 
artifacts. Remarkably, we further validated this deletion on total MDA and bulk OE 
samples, both samples which preceded Olfr2 locus-targeted PCR amplification.  
Although the high coverage in MDA compared with OE samples suggested that the 
deletion could be involved in Olfr2 expression we will need to demonstrate its 
functional role in vivo. To this purpose, in the near future we are going to set up a 
functional validation experiment. Taking advantage of crispr-cas9 technology we will 
reproduce the deletion in the genomic sequence of Olfr2 locus in OSN progenitors of a 
transient anosmic mouse. After OE regeneration, we expect to see a change in the 
number of GFP-positive Olfr2 expressing cells. 
So far, we just started thinking about a possible supporting mechanism for deletions 
found in Olfr2 locus. Remarkably, all the 6 PCR validated deletions in amplicon 1, 3, 4 
and 5 were characterized by the presence of two directed repetitive sites (DRSs) of few 
nucleotides at the immediate 5’ and 3’ sequence surrounding the deletion. Interestingly, 
only one DRS was found in the deleted sequence. 
Comparing different DRSs, we did not find any consensus motif, so further analysis 
is needed to characterized in detail each deletion structural pattern. 
Until now, we focused on amplicon 3 deletion and we noticed that the two DRSs (5’-
ATTTGAT-3’) map respectively on two different, annotated, 5’truncated LINE-1 
elements, distant 3555 bp from each other. Remarkably, they were both annotated on 
minus strand, which is the same strand from where Olfr2 is transcribed.  
Surprisingly, we found different alternative LINE-1 endonuclease cutting sites (Jurka 
1997) within the deleted sequence which mainly consist of annotated LINE-1 elements. 
In particular, “5’-TTAGAA-3’” and “5’-CTAAAA-3’” sites were present one time, “5’-
TTGAAA-3’” and “5’-TTAAAG-3’” were present three times (3.3). 
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Recently, it has been shown that overexpressed LINE-EN can create DNA DSBs 
preferentially on LINE-1 loci which harbor EN consensus sites themselves (Gasior et 
al.,2006; Erwin et al., 2016).  
While we are conscious that alternative mechanisms could be involved, we 
speculated that DSRs could support a micro-homology recombination mechanism, 
necessary for DSBs repair and possibly resulting in sequence deletion. A model for a 
supporting mechanism is represented by the SSA previously described in Figure 1.12. 
Interestingly, this pathway is active when a DSB occurs within a pair of directly 
repeated sequences (Pâques and Haber 1999). 
Similar observations were reported in the recent work of Gage and colleagues (Erwin 
et al., 2016). They identified several retrotransposition independent LINE-1 associated 
deletions in human brain (Erwin et al., 2016). In particular, they showed that the 
deletions were created by micro-homology recombination between A(n) microsatellite 
or fragile sites, triggered by LINE-1 EN cleavage at those sites. Indeed, LINE-1-EN-
induced DSBs preferentially occurred in LINE-1 sequences harboring themselves 
several EN cutting sites. This observation led to the hypothesis that the increase of 
LINE-1 retrotransposition during neuronal differentiation generates DSBs preferentially 
in LINE-1 loci.  
To prove that LINE-EN preferentially cuts at LINE-1 loci, they overexpressed LINE-
1 construct in HEK T cells and then performed ChIP-seq experiment for -H2AX. As 
expected, LINE-1 induced -H2AX peaks preferentially mapped on LINE-1 sequences. 
In our work, to investigate the possible involvement of DSB repair mechanisms in 
the formation of Olfr2 deletions, we performed a ChIP-Seq experiment for endogenous 
-H2AX (DSBs marker) in mouse OE and L. From this analysis we expected to see a 
preferential distribution of endogenous -H2AX within LINE-1 sequences in OR-loci in 
OE tissue compared with L.  
Interestingly, preliminary WB analysis for -H2AX in OE and L showed high 
expression of the endogenous DSBs marker in both tissues under physiological 
conditions. Unexpectedly, when looking at Chip-seq data, we found that both OE and L 
-H2AX peaks were depleted within LINE-1 sequences and were preferentially 
distributed outside the OR clusters.  
Depletion of -H2AX peaks within LINE-1 sequences suggested that the 
contribution of endogenous LINE-1-EN to DSBs in a normal tissues is probably too low 
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to be detectable by ChIP-seq experiment or is occurring at a certain time only in a very 
limited number of cells. 
 Looking then at Olfr2 cluster, we confirmed that OE -H2AX signal was depleted 
within the cluster except for one single peak. Indeed, one -H2AX peak (from OE 1m 
sample) was found within a region located about 15 kb upstream Olfr2 TSS. 
Intriguingly, that specific -H2AX peak was located between amplicon 1- and amplicon 
3-validated deletions, suggesting the presence of fragile sites in those regions. So far we 
can say that the deletion-associated -H2AX peak is characterized by a high number of 
supporting reads, suggesting it is a real signal. Further analyses are ongoing to outline a 
possible link to the generation of genomic deletions. 
 
4.5 Characterization of endogenous -H2AX in OE 
Even though ChIP-seq analysis of endogenous -H2AX in OE could not exhaustively 
suggest DSBs involvement in deletions, we decided to benefit from ChIP-Seq data to 
characterize endogenous -H2AX genomic distribution in OE and L tissues under 
physiological conditions. Indeed, several works investigated DNA-DSBs in cell lines 
upon treatment with IR or chemical compounds but little is know about DSBs naturally 
occurring in normal tissues.  
We performed ChIP-Seq experiment on OE at two ages, p6 and 1m, according to the 
mouse ages used for LINE-1 and SVs analyses. We chose L as “control” tissue for 
ChIP-seq analysis since L is a very well characterized homogenous tissue with a wide 
range of public datasets available. Moreover, OE and L are characterized by different 
cell types with different expression pattern. Interestingly, it was demonstrated that L is 
among the tissues with the fewest number of ectopically expressed ORs (Flegel et al. 
2013) 
Nevertheless, we cannot exclude that OE and L could share common biological 
features. Interestingly, one example is represented by the cytochrome P450, which is 
expresses specifically by the these two tissues (Reed, Lock, and De Matteis 1986). 
We started the analysis of ChIP-Seq data looking at the genomic distribution of -
H2AX peaks. Overall, -H2AX signal in OE and L presented very similar distribution 
patterns. Peaks were enriched in the regulatory (promoters and enhancers) and 
transcribed (gene bodies) portion of the genome. Consistently, the majority of peaks fall 
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within 0 and 10 kb downstream the annotated TSSs.  In addition, 75% of -H2AX peaks 
were localized within a DNAseI sensible site, suggesting a link between genomic 
instability and regulatory chromatin. Moreover, about 20-25% of peaks fall within CpG 
islands,  suggesting that at least part of the H2AX-bound DNA in physiological 
conditions is associated to CG rich regions. 
CG content has been previously related to function: for example, it has been reported 
that transcription start sites located within CpG islands have distinct features with 
respect to those located outside (Carninci et al. 2006; Sandelin et al. 2007). 
Interestingly, it was shown that GC-rich regions could be particularly vulnerable to 
certain types of DNA damage (Ma et al. 2011). Finally, GC-rich extracellular DNA has 
been shown to promote DSB in adipose-derived mesenchymal stem cells (Kostyuk et al. 
2015). 
We additionally performed a chromatin segmentation analysis. Overall, the three 
sample datasets showed very similar enriched patterns. -H2AX peaks were 
preferentially enriched for Pol II binding sites and histone modifications found on active 
promoters (H3K4me3, H3K9ac) and gene bodies (H3K36me3, H3K79me2). This is 
consistent with the observation that a very large proportion of the peaks is located in 
gene bodies and suggests that this deposition pattern is linked to a regulatory function of 
-H2AX within the gene bodies in physiological conditions. Moreover, chromatin 
segmentation analysis showed that about 20% of -H2AX peaks were enriched for 
histone modifications labeling active enhancers and distal regulatory regions (H3K27ac 
and H3K4me1, respectively) . This result further confirm preferentially distribution of 
-H2AX peaks for enhancers, suggesting DSBs. Recently, it has been demonstrated that 
Topoisomerase I nicking is required for ligand-dependent enhancer activation (Puc et al. 
2015). These results showed a link between transcription and DNA-damage repair 
response, where nicking is necessary to relieve topological stress due to DNA torsion, 
promoting enhancer transcription. 
Overall the general characterization of -H2AX showed that endogenous DSBs are 
not randomly distributed in the genome. Interestingly they are strongly associated with 
genes, promoters and active enhancers. 
In agreement, it has been previously shown that endogenous -H2AX signal was 
enriched in transcribed regions and at Pol II pausing sites, in human Jurkat cells (Seo et 
al. 2012b). Recently, endogenous DSBs have been characterized in normal human 
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keratinocytes showing their preferentially distribution in correspondence of DNAseI 
sensible sites and PolII binding sites (Lensing et al. 2016). 
To investigate further peaks association with genes we performed GO functional 
annotation. Surprisingly the biological processes associated with -H2AX peaks were 
very different for OE and L. Intriguingly, the only GO term enriched in OE 1m sample 
was clearly linked to olfaction, suggesting a link to tissue specific gene expression. 
Interestingly, about the 75 % of Pol II-overlapping peaks was associated to an active 
TSS in both OE and L datasets, confirming -H2AX link with transcription. We 
speculated that the left 25% of Poll II overlapping peaks, which did not overlap an 
active TSS, could represent signal associated to Pol II elongation sites. Indeed, Pol II 
elongation sites are located within the gene rather than in the TSS. Anyway, to confirm 
this hypothesis further analyses are needed. 
Moreover, we looked in details at peaks correlation with active TSSs in OE and L 
expression datasets. OE-active TSSs overlapping -H2AX peaks belonging to either of 
the three considered peak sets had higher expression levels with respect to OE-active 
TSSs not overlapping -H2AX peaks. We didn’t observe the same effect for OE-active 
TSSs overlapping a mock-up set of peaks randomly distributed along the genome. Even 
though there are no major differences between expression levels of OE-active TSSs 
within/outside the three peak sets considered, we noted that for both OE samples the 
expression levels of OE-active TSS within the peaks was higher than in L set.  
When we looked at L expression dataset we did not find the same evidence that TSSs 
active in liver overlapping -H2AX peaks have higher expression than those located 
more far away from the peaks. We cannot exclude that the weaker effect might be due 
to technical reasons related to the liver expression data.  
Finally, since we found a notably similar proportion of TSSs overlapped in the 
comparison with the two distinct expression datasets, we investigated the number of -
H2AX peaks overlapping active TSSs, in both OE and L datasets. As expected, for each 
sample, the large majority of peaks overlapping an active TSS in L, overlapped also an 
active TSS in OE. Given the moderate peak lengths, we can deduce that the overlapped 
TSSs are the same in both the two tissue datasets. 
Overall, expression-correlation results suggested that a portion of endogenous -
H2AX signal can be related to gene expression under physiological conditions. In 
particular, -H2AX peaks seem to be related to genes expressed by both OE and L 
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tissues rather than to tissue-specific genes. Further analyses are ongoing to investigate 
this issue. 
Moreover, RNA-seq of OE and L from the very same ChIP samples analyzed would be 
needed to increase the significance of our analysis. 
Finally, we investigated the -H2AX distribution with respect to CTCF insulator 
protein to assess whether DSBs could co-operate with CTCF in orchestrating long-
range chromosomal interactions. Indeed, previous analysis of human CTCF genome 
distribution demonstrated that CTCF-depleted domains included clusters of related 
genes that are transcriptionally co-regulated, supporting a role for CTCF-binding sites 
acting as insulators. Gene clusters, among which OR clusters, are surrounded by a pair 
of consecutive CTCF-binding sites in the genome (Kim at al., 2006). In addition, 
Tchurikov and colleaugues showed localization of DSBs and CTCF at the border of 
both expressed and silenced gene clusters (Tchurikov et al., 2013). Additional 
observations came from the work of Reimand and colleagues, where they demonstrated 
that type II Topoisomerase  (TopoII) binds CTCF binding sites flanking 
transcriptionally associated domains (TADs). Here, TopoII creating DNA-DSBs is 
involved in solving topological constrains (Uusküla-Reimand et al. 2016). In agreement 
with these observations, we first observed that 30% of -H2AX peaks fall inside CTCF 
binding sites, this was true for both OE and L. We then looked at 30% CTCF-
overlapping peaks distribution with respect to olfactory gene clusters. Interestingly, -
H2AX peaks were depleted inside the clusters, but preferentially distributed outside of 
them together with CTCF, suggesting a possible involvement for DBSs in mediating 
topological stress facilitating long range chromosomal interactions. The same 
distribution was observed for all 10 different gene clusters analyzed (3.4). 
Overall 77.6% (54.7%, 63.1%) of the Lp6 (OEp6 and OE1m respectively) peaks is 
associated to one among all the features we investigated (CTCF, DNAseI, Pol II, CpG 
and active TSSs) supporting functional roles previously associated to those features. 
Interestingly, the percentage is higher for the Lp6 peak set, consistently with the fact 
that most of the supporting data used in the comparison is liver-derived (in other words, 
for liver we have additional data which is fundamentally matching in terms of both 
tissue and age and for liver we have the highest “annotation coverage”). The remaining 
portions of the peaks results to be independent of those features, suggesting that they 
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could have a functional role that make them independent of the functional marks we 
investigated.  
4.6 Conclusion 
Taken together, the results of this work showed that endogenous LINE-1 elements 
are active in mouse OE under physiological conditions. Moreover, the high density of 
LINE-1 elements in OR-loci let us speculate that they have a possible regulatory 
function for the expression of OR genes. Genomic analysis of a particular OR locus 
showed a high degree of genomic complexity, characterized by high number of SVs 
among which LINE-1-associated deletions are the predominant variant. Finally, 
genome-wide analysis of endogenous DSBs in OE and L showed DNA damage is 
detectable in normal tissues, and are linked to transcribed and regulatory genomic 
regions.  
Overall, we conclude that the ability for LINE-1s to create DSBs, together with 
interspersed homology, suggested a role of TEs in increasing genetic instability in OR 
loci. Here, LINE-1 dependent structural variations could contribute to influence gene 
regulation of OR genes in a monoallelic and stochastic fashion. 
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Appendix A:  
Supplementary information for SV analysis in Olfr2 locus  
 
Figure-A1. MDA locus amplification PCR check. Right panel: 6 MDA amplification replicates from 10 
single cells; + = MDA performed on control gDNA; - = MDA performed without input DNA (negative 
control). Left panel: control PCR for Olfr2 coding sequence (CDS) on MDA amplifications. 

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Figure-A2. Long range PCR amplification for Pac Bio sequencing. For each MDA replicate as for 
bulk OE gDNA, 50 kb of Olfr2 locus amplification is shown. Green labels indicate examples of selected 
amplifications finally pooled together for sequencing. 
 
 
 
Figure-A 3. Pac Bio sequencing coverage of 50kb Olfr2 locus. Olfr2 50 kb locus coverage in MDA 
sample (left) and OE sample (right) is represented plotting the number of reads for the 50 kb locus 
coordinates. Minus strand, which is the strand of Olfr2 transcription, is shown. The numbers  “7” and “2” 
indicate the amplicons which were not correctly amplified. Reads mapped in amplicon 2 coordinates are 
not specific. 
 
 
Figure-A 4. Illumina coverage at 5’ and 3’ amplicons. Illumina coverage for each sample comparing 5’ 
and 3’ amplicons with respect to Olfr2 TSS. MDAV (red); MDAXI (green); OE (blue). 
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
Appendix B:  
Supplementary information for ChIP-Seq analysis  
 
 
 
Figure-B 1. Western blot for endogenous -H2AX on OE and L tissues. Whole tissue protein lysates 
from C57BL/6J OE (p6 and 1m) and L (p6) were analyzed for endogenous -H2AX expression. Anti--
H2AX antibody recognized both phosphorylated H2AX (-H2AX) in the yellow square and 
phosphorylated plus ubiquitinated H2AX (Ub-H2AX) in the green square, as expected from literature. 
Anti-H2AX was developed on the same gel and used as normalizer together with b-actin.  
 
 
Figure-B 2. Western blot for endogenous -H2AX on IP samples.  -H2AX-IP sample and IgG-IP 
sample protein lysates were incubated with anti--H2AX antibody. Total protein lysate from OE tissues at 
12m was used as positive control. 
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Figure-B 3. Correlation heatmap for ChIP-seq samples across all the conditions. The correlation 
analysis was performed by segmenting the dataset into bins of a defined length and calculating read 
abundance within the bins using as starting point directly the bam files used to call the peaks. The 
dendogram on the left grouped the biological replicates for each sample as expected. 
 
 
 
Figure-B 4. ChIP-seq sample peaks intersection. Venn diagram of peaks intersection among different 
ChIP-seq sample datasets. 
 
 
 
Table-B 1. ChIP-Seq Public datasets intersection. Pol II, DNAse and CTCF public datasets used for 
the analysis. We selected the best matching datasets available, Liver and OlfactoryBulb (OB). When OB 
was not available, we used dataset from whole brain. For each dataset the percentage of overlapping 
peaks is indicated. 
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
 
Figure-B 5. Percentage of peaks overalpping Pol II binding sites in different datasets. For each chart, 
the dataset used is indicated. Lp6 (red); OE1m (green); OEp6 (blue); random peaks (black). 
 
 
Figure-B 6. Percentage of peaks overalpping DNAseI sensible sites in different datasets. Lp6 (red); 
OE1m (green); OEp6 (blue); random peaks (black). 
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Figure-B 7. Percentage of peaks overalpping CTCF binding 
sites different datasets. Lp6 (red); OE1m (green); OEp6 (blue); 
random peaks (black)  
Figure-B 8. Peaks distribution with respect to the caryotype.  
Ensembl view of all mouse chromosomes. Chip-seq peaks are 
indicated with different color per sample: Liverp6 (red); OE1m 
(blue); OEp6 (green)  
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